<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id><journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id><journal-title-group><journal-title>The Journal of Headache and Pain</journal-title></journal-title-group><issn pub-type="ppub">1129-2369</issn><issn pub-type="epub">1129-2377</issn><publisher><publisher-name>Springer Milan</publisher-name><publisher-loc>Milan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6929435</article-id><article-id pub-id-type="publisher-id">1066</article-id><article-id pub-id-type="doi">10.1186/s10194-019-1066-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Mechanisms of migraine as a chronic evolutive condition</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7008-6626</contrib-id><name><surname>Andreou</surname><given-names>Anna P.</given-names></name><address><email>anna.andreou@headache-research.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Edvinsson</surname><given-names>Lars</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution>Headache Research, Wolfson CARD, Institute of Psychiatry, Psychology and Neuroscience, </institution><institution>King&#x02019;s College London, </institution></institution-wrap>London, UK </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0581 2008</institution-id><institution-id institution-id-type="GRID">grid.451052.7</institution-id><institution>The Headache Centre, Guy&#x02019;s and St Thomas&#x02019;, </institution><institution>NHS Foundation Trust, </institution></institution-wrap>London, UK </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution>Department of Medicine, </institution><institution>Lund University, </institution></institution-wrap>22185 Lund, Sweden </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>20</volume><issue>1</issue><elocation-id>117</elocation-id><history><date date-type="received"><day>13</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>3</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Understanding the mechanisms of migraine remains challenging as migraine is not a static disorder, and even in its episodic form migraine remains an &#x0201c;evolutive&#x0201d; chronic condition. Considerable progress has been made in elucidating the pathophysiological mechanisms of migraine, associated genetic factors that may influence susceptibility to the disease, and functional and anatomical changes during the progression of a migraine attack or the transformation of episodic to chronic migraine. Migraine is a life span neurological disorder that follows an evolutive age-dependent change in its prevalence and even clinical presentations. As a disorder, migraine involves recurrent intense head pain and associated unpleasant symptoms. Migraine attacks evolve over different phases with specific neural mechanisms and symptoms being involved during each phase. In some patients, migraine can be transformed into a chronic form with daily or almost daily headaches. The mechanisms behind this evolutive process remain unknown, but genetic and epigenetic factors, inflammatory processes and central sensitization may play an important role.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Migraine is a recurrent, disabling neurological disorder, involving intense head pain and associated with other unpleasant symptoms. Migraine affects about 15% of the general population [<xref ref-type="bibr" rid="CR1">1</xref>] and causes substantial personal suffering and impaired quality of life with a significant socioeconomic impact. The toll of chronic migraine on individual and society is even bigger, as up to 45% of patients presenting to headache clinics have daily or near-daily headaches [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], with nearly half of them in need of a migraine preventive treatment [<xref ref-type="bibr" rid="CR4">4</xref>]. The World Health Organization ranks migraine as the most prevalent, disabling, long-term neurological condition when taking into account years lost due to disability [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par3">Considerable progress has been made in elucidating the pathophysiological mechanisms of migraine, associated genetic factors that may influence susceptibility to the disease and functional and anatomical changes during the progression of a migraine attack, or the transformation of episodic to chronic migraine. However, understanding disease mechanisms remains challenging as migraine is not a static disorder, and even in its episodic form migraine remains an &#x0201c;evolutive&#x0201d; chronic condition.</p><sec id="Sec2"><title>Migraine as a life span disorder</title><p id="Par4">Migraine is a life span disorder affecting children, adults and the elderly. The clinical presentation of migraine shows an age-dependent change with shorter duration and also occurrence of special paroxysmal symptoms like vomiting, abdominal pain or vertigo in childhood and largely an absence of autonomic signs in the elderly.</p><p id="Par5">The prevalence of migraine in children varies, depending on the study and the age range of the included subjects, between 2.7% and 10.0% and in younger children (below 7&#x02009;years) it does not differ between girls and boys [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. In adulthood, migraine is more prevalent in women than in men with a lifetime prevalence of 12&#x02013;17% and 4&#x02013;6%, respectively [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. A factor that may contribute to the increased prevalence of migraine in women compared to men in the reproductive years is estrogen withdrawal which is a reliable trigger of menstrual attacks in women [<xref ref-type="bibr" rid="CR10">10</xref>]. Migraine in women usually declines after menopause [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], indicating further the influence of hormonal changes on migraine occurrence. The prevalence of migraine in the elderly is about 3.5% with females affected ~&#x02009;2 times more often than males [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par6">The clinical manifestation of migraine is different in childhood from that in adulthood. Pediatric migraine is characterized by shorter attacks with the pain being less often unilateral. Accompanying symptoms include mild intolerance to light and rarely to noise [<xref ref-type="bibr" rid="CR15">15</xref>], while vomiting and cranial autonomic features are significantly more frequent compared to adult patients [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par7">Beyond the influence of hormonal changes in women that can be partially responsible for the changes in the prevalence of migraine in adults and the elderly, another general feature seems to be a decrease in autonomic symptoms during aging. All these symptoms are associated with increased parasympathetic activity. A possible explanation is a change in the connectivity of hypothalamic areas to different autonomic control centres during aging in migraine [<xref ref-type="bibr" rid="CR18">18</xref>]. Readers interested in changes in migraine symptoms during lifespan, as well as, in mechanisms that may be driving these changes, are encouraged to read a recent review by Straube and Andreou [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec><sec id="Sec3"><title>Genetic and epigenetic component of migraine</title><p id="Par8">Genetic factors may determine susceptibility to migraine, while different environmental factors can contribute to the development of a migraine attack [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Mainly through genome-wide association studies (GWAS), which tested for differences in allele frequencies of single nucleotide polymorphisms (SNPs) over the genome in migraine patients and controls [<xref ref-type="bibr" rid="CR21">21</xref>], it is now understood that multigenetic variants, rather than individual genes, influence the susceptibility to migraine. Although GWAS in migraine, similarly to other disorders studied with GWAS [<xref ref-type="bibr" rid="CR22">22</xref>], failed to shed light on the molecular changes that are responsible for the evolutive nature of migraine, one can envisage that combined knowledge from many variants will highlight which molecular pathways potentially could be involved in migraine pathophysiology [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par9">In the latest GWAS which included samples from nearly 60, 000 patients and over 300,000 controls, 44 SNPs were associated with migraine without aura, implicating 38 distinct genomic loci [<xref ref-type="bibr" rid="CR23">23</xref>]. The majority of them were found to be implicated in molecular pathways related to vascular function. Other loci identified in this study, were involved in pathways related to metal ion homeostasis, leading to a rather unexpected, hypothesis that metal ion homeostasis might contribute to migraine susceptibility. Only a handful of loci was found to be involved in ion channel activity, with much less prominent signals [<xref ref-type="bibr" rid="CR20">20</xref>]. The importance of those compared to the outcomes related to vascular function, remains a matter of debate, as this study highlighted that vascular dysfunction is of great importance in migraine susceptibility with neuronal dysfunction playing a rather secondary role [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par10">Regardless of these outcomes, due to their small effect size no single SNP has any clinical use in predicting the risk of developing migraine. There is still a big challenge in the field of GWAS to link associated SNPs to actual genes and pathways. GWAS in migraine are yet to offer further knowledge on the functional consequences of the associated SNPs and how they influence susceptibility to migraine.</p><p id="Par11">On the other hand, genetic studies of hemiplegic migraine, a rare monogenic forms of migraine [<xref ref-type="bibr" rid="CR24">24</xref>] offered knowledge about specific genes that encode proteins involved in the function of ion channels and transporters. Specific mutations in these genes were studied in detailed and were shown to induce either loss or gain of function in cellular assays or in mutant murine. In brief, mutations involved in familial hemiplegic migraine were found in the genes <italic>CACNA1A</italic>, <italic>ATP1A2</italic> and <italic>SCN1A, which</italic> encode subunits of neuronal voltage-gated Ca<sub>V</sub>2.1 Ca<sup>2+</sup>, Na<sub>V</sub>1.1 Na<sup>+</sup> channels, and glial Na<sup>+</sup>K<sup>+</sup> ATPases, respectively. Interestingly a common consequence of these mutations is an increase in glutamate availability at the synaptic cleft of cells. Mutations in the <italic>CACNA1A gene</italic> can have as a consequence enhanced glutamate release due to enhanced calcium flux at the presynaptic terminal [<xref ref-type="bibr" rid="CR25">25</xref>]. Mutations in the <italic>ATP1A2</italic> gene result in a smaller electrochemical gradient for Na<sup>+</sup>. One effect of this is the reduction or inactivation of astrocytic glutamate transporters, leading to a build-up of synaptic glutamate [<xref ref-type="bibr" rid="CR26">26</xref>]. The <italic>SCN1A</italic> mutations can result in facilitation of high-frequency discharges that might also increase synaptic glutamate levels [<xref ref-type="bibr" rid="CR27">27</xref>]. Thus, the neurons at glutamatergic synapses can fire at a higher frequency than they do under normal conditions and this might explain the increased susceptibility to cortical spreading depression, the underlying mechanism of migraine aura [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Interestingly, mice carrying the <italic>CACNA1A mutation exhibit blunted trigeminovascular nociceptive responses and calcitonin gene-related peptide (CGRP) expression</italic> [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]<italic>.</italic></p><p id="Par12">Although genetic factors may be involved in the evolutive processes of migraine, to date they failed to explain the pathophysiology of migraine and evolutive mechanisms. However, it is important to mention the knowledge gained from such studies, as they are part of disease mechanisms and disease susceptibility, while in the future they may be able to explain better the mechanisms that transform migraine into a chronic form in some individuals or achieve migraine freedom altogether later in life.</p><sec id="Sec4"><title>Is there a role for epigenetic mechanisms in migraine susceptibility and chronification?</title><p id="Par13">Beyond genetic factors that could be responsible for migraine susceptibility and evolution to migraine chronification, epigenetic pathways through changes in DNA expression could also influence an individual&#x02019;s sensitivity to migraine. Epigenetics refers to modification of gene expression without altering the underlying DNA sequence. A main epigenetic mechanism is DNA methylation, the covalent addition of a methyl group to the fifth carbon of cytosine residues, which is typically associated with gene silencing. The cause of epigenetic changes in not well understood, but it can include environmental factors, early life events, inflammation, stress and brain plasticity.</p><p id="Par14">Epigenetics is a new area of research and only a handful of studies are done in migraine patients. Recently, the first genome-wide study of DNA methylation in headache chronification was published [<xref ref-type="bibr" rid="CR32">32</xref>]. Although, several potentially implicated loci and processes were identified, only in the combined meta-analysis statistical significance was found for two CpG sites which were related to two brain-expressed genes; <italic>SH2D5</italic> and <italic>NPTX2</italic>. The <italic>H2D5</italic> gene encodes the SH2 domain-containing 5 protein which is thought to regulate indirectly synaptic plasticity through the control of Rac-GTP levels. The <italic>NPTX2</italic> gene encodes the neuronal pentraxin II protein, an inhibitor of excitatory synapses, through binding and clustering of glutamatergic AMPA receptors. Both proteins are highly expressed in the adult human brain [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p id="Par15">A smaller pilot study aimed to identify changes in DNA methylation associated with headache chronification by characterising genome-wide DNA methylation levels in episodic migraineurs and patients suffering from chronic migraine with medication overuse headache (MOH), before and after detox programme. Although no statistical significance was found between the groups at different time points, some CpG sites of interest were identified, and are thought to be involved in drug addiction mechanisms and neuropsychiatric illness comorbid [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par16">These preliminary data seem to support a role of epigenetic processes migraine, and theoretically they could be involved in mechanisms of brain plasticity and other migraine-specific processes. However, considering that migraine, both in its episodic and chronic form, is a complex and multidimensional disorder, all these preliminary data require replication and validation in much larger samples.</p></sec></sec><sec id="Sec5"><title>Brain changes in the migraineur: is it a brain evolutive process?</title><p id="Par17">Beyond functional changes, differences in the structural brain integrity, involving both the white and gray matter, which evolve over time, have been reported by several studies between migraine patients and controls.</p><p id="Par18">The prevalence and volume of deep white matter lesions is increased in migraine patients, with women with migraine with aura having the highest prevalence [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]. Interestingly, these white matter lesions are not static and their development involves a gradual process for the evolution of focal invisible microstructural changes into focal migraine-related visible white matter lesions [<xref ref-type="bibr" rid="CR37">37</xref>]. Later studies showed long-term higher incidence of deep white matter brain changes, especially among female patients. These changes were related to an increased number of new lesions rather than an increase in the size of pre-existing lesions [<xref ref-type="bibr" rid="CR38">38</xref>]. In the ARIC MRI study [<xref ref-type="bibr" rid="CR39">39</xref>], the authors showed that although migraine has an increased insistence of white matter lesions, there is no progression overtime. The authors suggest that the association between migraine and white matter lesions is stable in older age and may be attributable to changes occurring earlier in life [<xref ref-type="bibr" rid="CR39">39</xref>]. Indeed, although white matter lesions are not as prevalent in children, they are not unusual [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>]. Whether these early life changes are attributed to genetic factors, remains to be established, however, the outcomes of the GWAS on vascular factors that may contribute to migraine susceptibility, may also suggest an increased susceptibility to white matter lesions.</p><p id="Par19">A number of studies showed cortical structural changes in migraine patients (detail reviews can be found here [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR47">47</xref>]. To this end there are conflicting results to whether there is cortical thinning or cortical thickening in the migraineur&#x02019;s brain. Such changes include, increased thickening in the somatosensory cortex of patients with migraine that does not differ between patients with and without aura, decreased grey matter in cingulate cortex and reduced volume of the medial prefrontal cortex, atypical age-related cortical thinning in episodic migraine, increased thickness of the left middle frontal sulcus and the left temporo-occipital incisure, as well as, reduced thickness of the left superior frontal sulcus and the left precentral sulcus [<xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR52">52</xref>]. A more recent multi-centre 3&#x02009;T MRI study utilising a large number of migraine patients [<xref ref-type="bibr" rid="CR53">53</xref>] demonstrated significant clusters of thinner cortex in the patients with migraine compared with control subjects [<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par20">Gray matter changes have been reported in the region of the thalamus and a reduced striatal volume in migraine subjects with and without aura. Studies have shown broad microstructural alterations in the thalamus of migraine patients that may underlie abnormal cortical excitability. These changes involve reduced volume in thalamic nuclei with dense connections to the limbic system, including the central nuclear complex, anterior nucleus and lateral dorsal nucleus [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Migraineurs were also found to have structural alterations of the brainstem with significant inward deformations in the ventral midbrain and pons, and outward deformations in the lateral medulla and dorsolateral pons [<xref ref-type="bibr" rid="CR57">57</xref>].</p><p id="Par21">An interesting study by Coppola and colleagues demonstrated that structural changes in the brain of episodic migraine patients without aura evolve over the course of the migraine cycle. Interictally, patients were shown to have a significantly lower gray matter density within the right inferior parietal lobule, right temporal inferior gyrus, right superior temporal gyrus, and left temporal pole when compared to healthy controls. Ictally, gray matter density increased within the left temporal pole, bilateral insula, and right lenticular nuclei, but no areas exhibited decreased density. The authors suggested that these morphometric changes between ictal and interictal phases indicate abnormal structural plasticity [<xref ref-type="bibr" rid="CR58">58</xref>]. Whether these changes are an important mechanism of migraine pathology remains to be evaluated. If indeed these data can be reproduced, they demonstrate that evolutive processes happen in the migraineur&#x02019;s brain constantly and in a cycling manner.</p><p id="Par22">In CM patients, white-matter abnormalities were found in the brainstem and cerebellum [<xref ref-type="bibr" rid="CR59">59</xref>]. Other studies showed, that CM is associated with subtle gray matter volume changes in several brain areas known to be involved in nociception/anti-nociception, multisensory integration, and analgesic dependence [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. Gray matter changes, have been reported to correlate with headache frequency assessed in both episodic and chronic migraine [<xref ref-type="bibr" rid="CR60">60</xref>]. Recently, another study demonstrated alterations in the region of the hypothalamus, with the volume of the hypothalamus being significantly decreased in both episodic and chronic migraine patients, which in CM was positively correlated with headache frequency [<xref ref-type="bibr" rid="CR62">62</xref>]. Bigger longitudinal volumetric neuroimaging studies with larger groups, especially on the chronification of migraine, are needed to understand the evolutive nature of these changes.</p><p id="Par23">What causes these structural changes in the migraine brain is not known. Some alterations may be due to a genetic susceptibility towards developing migraine attacks. To this end, structural brain studies in paediatric migraine patients, could shed more light in the cause of this structural changes. A small MRI study showed significant alterations in brain volume. Compared to controls, paediatric migraine patients experienced a significant gray matter loss in several areas of the frontal and temporal lobes which are part of the pain-processing network, while they had increased gray matter volume of the right putamen. Between patients with aura compared to patients without aura, the left fusiform gyrus had an increased volume. In the paediatric population of migraine these structural changes were not correlated with disease duration and attack frequency [<xref ref-type="bibr" rid="CR63">63</xref>]. A more recent study that used MRI apparent diffusion coefficient (ADC) found no volumetric changes in paediatric migraine patients, but demonstrated increased ADC in the region of the hippocampus, brain stem and the thalamus [<xref ref-type="bibr" rid="CR64">64</xref>]. Although these studies used a smaller number of patients, data suggest that brain abnormalities do occur early on in migraine patients and the absence of correlation with patient clinical characteristics suggest that they may represent a phenotype developed as a consequence of genetic susceptibility.</p><p id="Par24">Other changes could be a consequence of repeated head pain attacks. Such structural changes can be the result of brain plasticity, which is defined as the ability of the brain to modify its own structure and function following changes within the body or in the external environment. A number of CNS changes can contribute towards gray matter changes, such as synaptogenesis, angiogenesis, glia genesis, neurogenesis, increase in cell size, increase in myelin size and increase in blood flow or interstitial fluid. White matter changes are usually the result of axonal remodelling and changes in blood flow [<xref ref-type="bibr" rid="CR65">65</xref>]. Despite the number of reports of structural changes in the migraineur&#x02019;s brain, their importance in the biology of migraine remains uncertain. Nevertheless, the existence of structural changes, suggest that migraine induces progressive anatomical transformation in the brain that may have an evolutive role in disease progression and associated disability.</p></sec><sec id="Sec6"><title>The evolutive migraine attack</title><p id="Par25">Migraine is cyclic disorders with a complex sequence of symptoms within every headache attack. In its episodic form, migraine is characterised by recurrent attacks involving different phases: (a). A premonitory phase prior to the onset of the actual headache, characterised by symptoms, such as excessive yawning, thirst, somnolence, food craving, cognitive difficulties, and mood changes [<xref ref-type="bibr" rid="CR66">66</xref>] (b). Transient neurological symptoms, known as migraine aura (typically visual alterations), that occur just before the actual headache starts [<xref ref-type="bibr" rid="CR67">67</xref>]. (c). An intense headache attack, usually involving only one site of the head, which can be exacerbated by movement and accompanied with hypersensitivity to sensory stimuli (e.g. light and smells), nausea [<xref ref-type="bibr" rid="CR68">68</xref>]. (d) The postdrome phase which is mainly characterised by symptoms of fatigue, difficulties in concentration and comprehension, and neck stiffness [<xref ref-type="bibr" rid="CR69">69</xref>]. During the interictal phase, although patients may appear normal, genetic predisposition and a number of triggers make them susceptible to an attack.</p><p id="Par26">Several factors may trigger migraine; stress and lack of sleep are probably the most common [<xref ref-type="bibr" rid="CR70">70</xref>]. Significant advances have been made in characterising migraine as a brain disorder and in identifying evolutive functional changes in different brain areas during the different phases of a migraine attack (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). However, despite the number of studies on pain pathways involved during the headache phase [<xref ref-type="bibr" rid="CR71">71</xref>], the molecular changes that actually trigger a migraine attack in the brain remain unknown. The lack of such knowledge had significantly hampered the design of migraine-specific and effective preventive treatments for a long time. Emerging evidence, partly obtained through use of the newly designed migraine treatments designed against the calcitonin gene-related peptide (CGRP) and its receptors [<xref ref-type="bibr" rid="CR72">72</xref>], further highlights an important role of the trigeminal system in driving migraine attacks.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Migraine is cyclic disorders with a complex sequence of symptoms within every headache attack. In its episodic form, migraine is characterised by recurrent attacks involving different phases, with a complex sequence of symptoms within every phase. Significant advances have been made in characterising migraine as a brain disorder and in identifying evolutive functional changes in different brain areas during the different phases of a migraine attack</p></caption><graphic xlink:href="10194_2019_1066_Fig1_HTML" id="MO1"/></fig></p><sec id="Sec7"><title>The premonitory phase and the triggering mechanisms of migraine</title><p id="Par27">Accumulating evidence exists as to why the trigger of migraine attacks should be sought in the hypothalamus. The hypothalamus is a small brain structure, consisted by a number of different nuclei with distinct neuropharmacology and function. Its multitude of functions can, in a broader sense, be described as functions that organise the circadian rhythms, control and maintain the homeostasis and regulate arousal [<xref ref-type="bibr" rid="CR73">73</xref>].</p><p id="Par28">Migraine onset appears to have a circadian rhythmicity. Migraine attacks tend to occur in a daily, monthly or even seasonal pattern, further suggesting a role for hypothalamic areas, responsible for the entrained biological clock-function, in the development of the disease [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Morphological and functional gender differences in several nuclei of the hypothalamus, may be also responsible for the monthly, menstrual associated migraine attacks, and the increased prevalence of migraine in women (~&#x02009;3:1) [<xref ref-type="bibr" rid="CR76">76</xref>].</p><p id="Par29">The premonitory symptoms of migraine are strongly associated with homeostatic functions regulated by the hypothalamus, such as arousal, sleep and feeding. The strongest, direct evidence for hypothalamic activation in migraine patients arises from brain imaging studies. These studies demonstrated, using positron emission tomography, increased blood flow in the region of the hypothalamus during the very early stages of spontaneous migraine attacks [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>] and during the premonitory phase of nitroglycerin (nitric oxide-NO donor)-induced migraine attacks [<xref ref-type="bibr" rid="CR79">79</xref>].</p><p id="Par30">A disturbance in homeostatic function is a significant trigger of attacks [<xref ref-type="bibr" rid="CR70">70</xref>]. Sleep/arousal physiology in particular, deserves greater attention as sleep disturbances can trigger attacks in over 50% of migraine sufferers. Additionally, patients with both episodic and chronic migraine are more prone to have their attacks in the morning [<xref ref-type="bibr" rid="CR80">80</xref>]. Morning headaches are also common in patients with sleep disorders, while post-operative migraine attacks in patients are common following anaesthesia [<xref ref-type="bibr" rid="CR81">81</xref>]. Importantly, sleep itself has a striking effect as an abortive strategy [<xref ref-type="bibr" rid="CR82">82</xref>], particularly for the majority of patients who find no relief by pharmacological treatments. The discovery of a mutation in the clock-gene <italic>CK1&#x003b4;</italic>, causing so called familiar advanced sleep phase syndrome, was strongly linked to migraine both clinically and experimentally in mice engineered to carry this mutation [<xref ref-type="bibr" rid="CR83">83</xref>]. The increased comorbidity of migraine in narcolepsy [<xref ref-type="bibr" rid="CR84">84</xref>] and sleepwalking [<xref ref-type="bibr" rid="CR85">85</xref>], also supports that migraine is an arousal-related disorder.</p><p id="Par31">Such evidence highlights that the posterior region of the hypothalamus containing the circuitry for governing arousal and the transition between sleep and wake, has a key role in the triggering of migraine. However, which hypothalamic nuclei, neurotransmitters and through which mechanisms, may be implicated has not been investigated. Although several neurochemical pathways may be involved in migraine pathophysiology [<xref ref-type="bibr" rid="CR86">86</xref>], of them, dopaminergic mechanisms appear to play some role, as yawning, a dopaminergic-driven function, is a prevalent symptom during the premonitory phase of migraine. In animal models the dopaminergic A11 nucleus of the hypothalamus has been shown to project to the trigeminocervical complex [<xref ref-type="bibr" rid="CR87">87</xref>], an important relay system involved in migraine, and to modulate activation of the ascending trigeminothalamic pathway [<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. Additionally, the A11 nucleus has been shown to be susceptible to nitric oxide donors in animal models of migraine [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>].</p><p id="Par32">Of interest, an fMRI study of daily brain scans in a migraine patient reported a strong association for both hypothalamic and cortical activity during the premonitory phase of an attack [<xref ref-type="bibr" rid="CR78">78</xref>]. The involvement of the occipital cortex in migraine has been long recognised, in particular because of the visual aura phenomenon. Electrophysiological studies and studies using transcranial magnetic stimulation, suggest that migraineurs have altered cortical activity, with the cortex, particularly the occipital region, appearing hyperactive [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. A study of photophobia during spontaneous migraine attacks using PET imaging also found that this migraine symptom is linked with visual cortex hyperexcitability [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref>]. It has been suggested that thalamo-cortical dysrhythmia in migraine patients may be responsible for abnormal cortical responses [<xref ref-type="bibr" rid="CR96">96</xref>]. Hence, a focal cortical treatment for migraine without systemic side effects is an attractive treatment opportunity. To this end, single pulse TMS (sTMS) has been shown to supress activation of the ascending trigemino-thalamic pathway [<xref ref-type="bibr" rid="CR97">97</xref>] and is now an approved migraine treatment with good efficacy in the acute and preventive treatment of migraine [<xref ref-type="bibr" rid="CR98">98</xref>&#x02013;<xref ref-type="bibr" rid="CR100">100</xref>].</p></sec><sec id="Sec8"><title>The migraine aura</title><p id="Par33">Migraine with aura symptoms are typically seen in about 15&#x02013;20% of patients [<xref ref-type="bibr" rid="CR101">101</xref>] and usually they develop gradually over 15&#x02013;20&#x02009;min and last less than 60&#x02009;min [<xref ref-type="bibr" rid="CR68">68</xref>]. It is now believed that the aura is the result of so called cortical spreading depression (CSD) [<xref ref-type="bibr" rid="CR102">102</xref>]. fMRI studies that tried to capture or simulate aura in migraine patients also pointed to a role for CSD as a mechanism for migraine aura [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>]. CSD is a wave of cortical neuronal depolarisation, linked with depressed neuronal activity and blood flow changes [<xref ref-type="bibr" rid="CR105">105</xref>], which in migraine is believed to spread out from the occipital cortex. In animals, CSD is an NMDA-receptor depended process and can be induced by cortical stimulation [<xref ref-type="bibr" rid="CR106">106</xref>]. It remains enigmatic how CSD is triggered in patients during migraine aura. Potentially, if indeed cortex is hyperactive in patients, this hyperactivity could trigger a CSD in certain susceptible patients. As previously mentioned genetic predispositions and environmental factors may modulate individual susceptibility by lowering the CSD threshold and cortical excitation may cause sufficient elevation in extracellular K<sup>+</sup> and glutamate to initiate CSD [<xref ref-type="bibr" rid="CR26">26</xref>]. Of interest, blood flow changes suggest a functional role for the cortex and this has also been recorded in migraine patients without aura [<xref ref-type="bibr" rid="CR102">102</xref>].</p><p id="Par34">The discussion of CSD-induced headache in migraine is still a matter of debate, as not every migraine patient experiences migraine aura, while the occurrence of aura without a headache is not uncommon [<xref ref-type="bibr" rid="CR107">107</xref>]. In experimental animal modes, CSD was shown to induce edema, reflex middle meningeal vasodilation and increases neural activity in the ipsilateral trigeminal ganglion and trigeminal nucleus [<xref ref-type="bibr" rid="CR108">108</xref>&#x02013;<xref ref-type="bibr" rid="CR111">111</xref>]. It was demonstrated that the trigeminal activation produced by experimental CSD may cause inflammation in the meninges that occurs after the CSD has subsided [<xref ref-type="bibr" rid="CR112">112</xref>]. Contradicting preclinical data to these previous findings also exists [<xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. An alternative hypothesis suggests that CSD activates cortico-thalamic fibres that in turn sensitize third order neurons of the ascending trigemino-thalamic pathway [<xref ref-type="bibr" rid="CR115">115</xref>].</p></sec><sec id="Sec9"><title>The headache phase</title><p id="Par35">The headache phase of migraine involves activation of the ascending trigeminothalamic pathway. Through early observations in humans who underwent awake brain surgery, it became well established that the pain during a migraine attack is perceived to be felt on intracranial structures, such as, the dura matter and intracranial vasculature [<xref ref-type="bibr" rid="CR116">116</xref>]. The sensory innervation of these structures arises from the trigeminal nerve, mainly from unmyelinated C-, and thinly myelinated A&#x003b4;-fibres, which have their cell bodies in the trigeminal ganglion. Nociceptive activation of the trigeminal fibres is referred to as &#x0201c;trigeminovascular activation&#x0201d;. The trigeminal fibres that transmit sensory information from such intracranial structures synapse on second-order neurons within the trigeminocervical complex (TCC; trigeminal nucleus caudalis, C1 and C2 spinal levels). These neurons give rise to the main ascending trigemino-thalamic pathway that relays sensory information to third order neurons, mainly in the contralateral thalamus, before processing the information to higher cortical areas.</p><p id="Par36">The thalamus is a pivotal nucleus for multisensory integration and may be a strong candidate for influencing neuronal excitability in migraine. The thalamic area is a prominent site of action of triptans [<xref ref-type="bibr" rid="CR117">117</xref>], of clinically active preventives [<xref ref-type="bibr" rid="CR118">118</xref>, <xref ref-type="bibr" rid="CR119">119</xref>] and of other potential anti-migraine compounds [<xref ref-type="bibr" rid="CR120">120</xref>]. Neuroimaging and electrophysiological studies have revealed altered network connectivity between the thalamus and pain modulating/pain encoding cortical areas during spontaneous migraine attacks, as well as, thalamo-cortical dysrhythmia which correlate with migraine symptoms [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]. Recently, a dynamic functional connectivity study in migraine patients between attacks demonstrated abnormal thalamo-cortical network dynamics, with the medial and posterior thalamic nuclei identified in intrinsic subcortical connectivity networks [<xref ref-type="bibr" rid="CR123">123</xref>]. The role of the thalamus in migraine deserves higher attention given its involvement in the development of associated symptoms, such as hypersensitivity to visual stimuli [<xref ref-type="bibr" rid="CR124">124</xref>], while thalamo-cortical activation may also participate in the development of auditory sensitivity [<xref ref-type="bibr" rid="CR125">125</xref>]. Furthermore, sensitization of third order thalamic neurons has been implicated in the development of non-cranial allodynia that is frequently seen in migraine patients [<xref ref-type="bibr" rid="CR126">126</xref>].</p><p id="Par37">A complex of descending networks from multiple brainstem, midbrain and cortical nuclei modulate the excitability of the ascending trigemino-thalamic pathway [<xref ref-type="bibr" rid="CR127">127</xref>]. In the absence of any evidence of malfunction in the peripheral trigeminovascular system, a disruption of normal endogenous descending modulatory tone may play a critical role in migraine. To this end, a number of brain imaging studies showed increased blood flow in the region of the dorsal rostral pontine and brainstem in both episodic [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>] and chronic migraine patients [<xref ref-type="bibr" rid="CR130">130</xref>]. A great limitation of brain imaging to date, is the lack of spatial resolution. Hence, it remains a lot of future research to delineate which descending networks and neurotransmitters that potentially are involved. Candidate nuclei include the periaqueductal gray, locus coeruleus, dorsal raphe nucleus and nucleus raphe magnus. Initially, these loci were considered as the migraine generator, due to the persistent blood flow increased in the rostral pontine area following headache relief [<xref ref-type="bibr" rid="CR131">131</xref>]. However, the increased blood flow in this region may be expected given the role of the brainstem in descending modulatory control of pain. What is interesting is that functional connectivity fMRI studies between attacks, have identified numerous brain regions and functional networks with atypical functional connectivity in migraineurs, and demonstrated interictal impairment of the descending pain modulatory circuits, potentially indicating a reduction of pain inhibition in migraineurs [<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par38">The puzzle of migraine pathophysiology is still incomplete, as we are yet to understand how hypothalamic dysfunction may lead to activation of the ascending trigeminothalamic pathway (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Activation of indirect pathways, involving brainstem nuclei as discussed above may indeed be a possibility. Alternatively, pathways arising from the hypothalamus that project directly to the TCC or the sensory thalamus, such as the dopaminergic A11 nucleus or the histaminergic tuberomammillary nucleus, both located in the posterior region of the hypothalamus, may directly alter the function of the ascending trigeminothalamic pathway.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Migraine pathophysiology involves activation of the hypothalamic region during the early premonitory phase, and activation of the trigeminal system during the headache phase. Cortical spreading depression (CSD) is thought to be the biological process of the migraine aura. How activation of the hypothalamus may lead to the development of CSD and activation of the trigeminal system remains unknown. Potentially the hypothalamus may activate direct or indirect pathways involving other brain areas, such us the brainstem, or the parasympathetic system, leading to the development of migraine aura and activation of the ascending trigeminothalamic pathway</p></caption><graphic xlink:href="10194_2019_1066_Fig2_HTML" id="MO2"/></fig></p><p id="Par39">An equally important pathway may be the trigeminal autonomic activation in migraine driven by the hypothalamus. Although autonomic features in migraine are not as prominent as in trigeminal autonomic cephalalgias, increased parasympathetic activity signs can be frequent [<xref ref-type="bibr" rid="CR132">132</xref>]. Clinical evidence suggest that subjects with cranial autonomic symptoms have a hyperactive efferent arm of trigeminal autonomic reflex [<xref ref-type="bibr" rid="CR132">132</xref>]. The hypothalamus is regulating the autonomic system and may indeed drive indirectly activation of the trigeminal system through the trigeminal-autonomic arc. The vast majority of parasympathetic fibers innervating the cerebral blood vessels originate from the sphenopalatine and the otic ganglia [<xref ref-type="bibr" rid="CR133">133</xref>]. Sphenopalatine ganglion block in migraine patients with autonomic features was found to relieve the pain intensity by over 50% [<xref ref-type="bibr" rid="CR134">134</xref>]. These findings suggest that increased parasympathetic tone contributes to the activation of perivascular nociceptors contributing significantly to the pain intensity and possibly to the initiation of central sensitization [<xref ref-type="bibr" rid="CR135">135</xref>]. This could also explain a brain-driven activation of the peripheral trigeminal system and the release of CGRP from trigeminal fibers and cells located in the trigeminal ganglion. The increased cranial parasympathetic outflow and modulation of the trigeminal autonomic reflex by the hypothalamus in migraine may be of great importance.</p><sec id="FPar1"><title>The trigeminal system and its role in sustaining the head pain in migraine</title><p id="Par40">Despite the various evidence of increased blood flow changes in different brain nuclei before or during the onset of the headache phase, what really alters the excitability of the ascending trigemino-thalamic pathway in a manner that a migraine headache may develop in susceptible individuals remains to be revealed. Several lines of evidence suggest that the peripheral trigeminal system is of pivotal importance in driving the headache;
<list list-type="alpha-lower"><list-item><p id="Par41">The referred pain patterns of migraine headache are similar to the locations of referred pain after stimulation of meningeal and cerebral arteries, as observed in awake patients during brain surgery [<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR136">136</xref>&#x02013;<xref ref-type="bibr" rid="CR138">138</xref>]. The importance of these pain-sensing structures is their vast innervation by trigeminal fibres.</p></list-item><list-item><p id="Par42">CGRP levels are increased during migraine attacks. Blood samples from patients or animal models during stimulation of the trigeminal fibres suggest that the origin of the CGRP found in migraine patients is indeed from the trigeminal nerve [<xref ref-type="bibr" rid="CR139">139</xref>&#x02013;<xref ref-type="bibr" rid="CR141">141</xref>]. CGRP is a potent vasodilator in the periphery and a modulator of nociceptive activity centrally. On second order neurons, CGRP has no effect on spontaneous neuronal firing but it can facilitate glutamatergic activity and nociceptive activation [<xref ref-type="bibr" rid="CR142">142</xref>&#x02013;<xref ref-type="bibr" rid="CR144">144</xref>].</p></list-item><list-item><p id="Par43">Chemicals that do not cross, the otherwise intact, blood-brain barrier (BBB) in sufferers [<xref ref-type="bibr" rid="CR145">145</xref>&#x02013;<xref ref-type="bibr" rid="CR147">147</xref>], such as CGRP and histamine, can trigger a migraine attack [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]. It is worth pointing out that the origin of the pain is not vasodilation as originally thought, as the migraine headache is not associated with cerebral or meningeal vasodilation [<xref ref-type="bibr" rid="CR150">150</xref>], and hence anti-migraine treatments may not require vasoconstrictor properties. Additionally, healthy controls are not susceptible (or respond to a much lower degree) to migraine headache following provocation with such chemicals, suggesting that the trigeminal system in migraine patients is sensitized.</p></list-item><list-item><p id="Par44">Effective migraine treatments, like the hydrophilic sumatriptan, the large monoclonal antibodies against the CGRP system and the peripherally injected botulinum toxin [<xref ref-type="bibr" rid="CR151">151</xref>&#x02013;<xref ref-type="bibr" rid="CR153">153</xref>], do not cross the BBB. Hence, any direct or indirect mechanism of action involves the peripheral trigeminal fibres and the trigeminal ganglion that are outside the BBB [<xref ref-type="bibr" rid="CR154">154</xref>].</p></list-item></list></p><p id="Par45">The above evidence, do not suggest that the peripheral arm of the trigeminal system is the cause of migraine, but demonstrate an important role for the peripheral trigeminal system in migraine headache. This evidence further suggests that treatments that can block activation of this system could be effective in suppressing migraine, but not necessarily the generator of migraine attacks. The trigeminal system, as well as, the trigemino-thalamic pathway in the CNS, are excitatory pathways, with glutamate being the major excitatory neurotransmitter [<xref ref-type="bibr" rid="CR120">120</xref>]. An ideal treatment for migraine would block the glutamatergic transmission along these pathways, as this will inhibit painful signals reaching pain processing cortical centres. However, central glutamatergic blockade is challenging due to severe adverse events that can develop by inhibiting glutamatergic transmission, although not impossible [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR118">118</xref>]. Peripherally acting glutamate agonists and antagonists may offer a more promising treatment approach [<xref ref-type="bibr" rid="CR155">155</xref>, <xref ref-type="bibr" rid="CR156">156</xref>].</p></sec><sec id="FPar2"><title>Vascular changes in migraine</title><p id="Par46">Vascular changes in migraine were for a long time considered the driver of migraine pain. In 1940 Ray and Wolff reported that stimulation or distension of the large cranial arteries evoked head pain associated with nausea [<xref ref-type="bibr" rid="CR116">116</xref>]. Distention of the distal internal carotid artery and middle cerebral artery during balloon inflation in patients with intracerebral arteriovenous malformations, can induce focal headache [<xref ref-type="bibr" rid="CR157">157</xref>]. Several studies attempted to analyse the role of the dural vasodilation by measuring blood vessel diameter during an attack. A 3&#x02009;T magnetic resonance angiography (MRA) study during a spontaneous migraine attack showed no significant changes of the diameter of middle meningeal artery (MMA) during a spontaneous migraine attack [<xref ref-type="bibr" rid="CR158">158</xref>], however a larger study in cilostazol-induced migraine attacks, found that the onset of migraine is associated with increase in MMA circumference specific to the headache side [<xref ref-type="bibr" rid="CR159">159</xref>]. In different studies in migraine patients with unilateral headache, headache was associated with intracranial dilatation of the middle cerebral artery (MCA) on the painful side, which was normalised after treatment with sumatriptan [<xref ref-type="bibr" rid="CR160">160</xref>], as well as, with dilatation of the temporal artery [<xref ref-type="bibr" rid="CR161">161</xref>]. Spontaneous dilatation alone cannot explain migraine pain, as arteries may dilate markedly, such as during blood pressure decreases, without induction of a migraine attack. In a nitroglycerin-triggered migraine study, peak dilation of the MCA occurred during the infusion phase of nitroglycerin. However, a migraine attack fulfilling the International Headache Society diagnostic criteria occurred ~&#x02009;5&#x02009;h post infusion, suggesting a role of the cGMP pathway in the development of a migraine attack, rather than the vasodilation itself. These evidences suggest that mechanical dilatation is not adequate to activate nociceptors and cause migraine headache [<xref ref-type="bibr" rid="CR162">162</xref>], and indeed, migraine can be induced, e.g. by sildenafil, without initial dilatation of the middle cerebral artery [<xref ref-type="bibr" rid="CR163">163</xref>].</p><p id="Par47">While it may be reasonable at this point to discard vasodilation as a direct cause of migraine, more studies are needed before eliminating blood vessels from the list of factors contributing to the pathophysiology of migraine. Both normal and pathological events occurring within and between vascular cells could mediate bi-directional communication between vessels and the nervous system, without the need for changes in vascular tone [<xref ref-type="bibr" rid="CR164">164</xref>]. Blood vessels consist of a variety of cell types that both release and respond to numerous mediators including growth factors, cytokines, adenosine triphosphate (ATP), and nitric oxide (NO), many of which can sensitize trigeminal neurons. In addition, the majority of genomic loci identified in GWAS to be associated with migraine without aura are involved in pathways associated with vascular function [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Hence, it could still be possible that blood vessels play a role in migraine pathophysiology in the absence of vasodilation.</p></sec></sec><sec id="Sec10"><title>The postdrome phase</title><p id="Par48">About 80% of migraine patients report at least one non-headache symptom following the end of their headache, while the disability scores remain high [<xref ref-type="bibr" rid="CR69">69</xref>]. The migraine postdrome is the least studied and least understood phase of migraine. Only recently, functional imaging showed widespread reduction in brain-blood flow in the postdrome, but at least some persistent blood flow increase in the occipital cortex [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR165">165</xref>].</p></sec></sec><sec id="Sec11"><title>The evolutive process of migraine chronification</title><p id="Par49">Chronic migraine (CM) is a disabling, underdiagnosed and undertreated disorder, affecting ~&#x02009;1&#x02013;2% of the general population [<xref ref-type="bibr" rid="CR166">166</xref>, <xref ref-type="bibr" rid="CR167">167</xref>]. Progression from episodic to chronic migraine is a clinical reality [<xref ref-type="bibr" rid="CR168">168</xref>, <xref ref-type="bibr" rid="CR169">169</xref>]. Studies show that each year 2.5% of episodic migraine patients progress into chronic migraine [<xref ref-type="bibr" rid="CR170">170</xref>] which appears as a distinct entity in the classification of the International Headache Society (chronic migraine &#x0003e;&#x02009;15 migraine days per month) [<xref ref-type="bibr" rid="CR68">68</xref>]. The nosology of CM has several clinical implications, including the elimination of modifiable risk factors and the therapeutic preventive options for CM patients.</p><p id="Par50">Patients with chronic migraine, have a significantly higher incidence of positive family history of migraine, menstrual aggravation of migraine, identifiable trigger factors, associated symptoms, and early morning awakening with headache [<xref ref-type="bibr" rid="CR171">171</xref>]. A number of risk factors have been identified to double the risk for migraine chronification [<xref ref-type="bibr" rid="CR172">172</xref>], including de novo increased migraine attack frequency and overuse of acute migraine medications [<xref ref-type="bibr" rid="CR173">173</xref>&#x02013;<xref ref-type="bibr" rid="CR175">175</xref>], ineffective acute treatment that could lead to medication overuse [<xref ref-type="bibr" rid="CR176">176</xref>], depression [<xref ref-type="bibr" rid="CR177">177</xref>], which is a common comorbidity of migraine, and lifestyle factors such as stress, high caffeine intake and obesity [<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR178">178</xref>].</p><p id="Par51">Certainly, either genetic factors or the presence of CM itself, induce functional and plastic changes in the brain of patients. In a recent resting-state fMRI study in chronic migraine patients without medication overuse it was shown that CM can progressively induce modifications in the CNS including large-scale reorganisation of functional cortical networks and interactive neuronal networks including the default mode network, the executive control network and the dorsal attention system [<xref ref-type="bibr" rid="CR179">179</xref>]. These are interesting outcomes as CM can impair the attention network resulting in impairment in executive functions [<xref ref-type="bibr" rid="CR179">179</xref>]. Additionally, a number of brain imaging studies showed changes in gray matter volume, as well as in white matter hyperintensities in CM patients, compared to episodic patients [<xref ref-type="bibr" rid="CR180">180</xref>&#x02013;<xref ref-type="bibr" rid="CR184">184</xref>]. Whether such structural changes have any potential functional consequences remains unknow.</p><p id="Par52">The physiological mechanisms that underlie the development of chronic migraine from its episodic form are not understood. Cortical excitability appears to be abnormal in chronic migraine patients, but this could be a consequence of the disease and not a driver of the chronification [<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR186">186</xref>]. Here we will discuss the role of inflammation and central sensitization in the evolutive process of chronic migraine.</p><sec id="Sec12"><title>Inflammation and central sensitization in the pathophysiology of migraine chronification</title><p id="Par53">The question whether inflammation could contribute in the activation of the trigeminal system in a manner that could drive the migraine headache and be implicated in the evolutive process of migraine chronification remains relevant in migraine pathophysiology and treatment [<xref ref-type="bibr" rid="CR187">187</xref>]. Indeed, the broad use of non-steroidal anti-inflammatory drugs for the acute treatment of headache supports the involvement of some neuroimmune responses in the development of migraine [<xref ref-type="bibr" rid="CR188">188</xref>, <xref ref-type="bibr" rid="CR189">189</xref>], while steroid injections in the region of the greater occipital nerve, are widely used as a preventive method in chronic migraine [<xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR191">191</xref>].</p><p id="Par54">In animals, sustained CGRP release may induce peripheral sensitization [<xref ref-type="bibr" rid="CR192">192</xref>] likely due to release of inflammatory mediators (bradykinin, prostaglandins, etc.) from nerve endings and cells of immune system [<xref ref-type="bibr" rid="CR193">193</xref>&#x02013;<xref ref-type="bibr" rid="CR195">195</xref>]. During a migraine attack that can last for up to 72&#x02009;h, the levels of the neuropeptide CGRP is increased [<xref ref-type="bibr" rid="CR139">139</xref>]. This leads to continuous activation of C-fibers because they store CGRP and of A&#x003b4;-fibers which contains CGRP receptors. This activation may lead to production and release of inflammatory cytokines, not only in the dura, but possibly also in neuronal cell bodies, which are localized in the TG. In addition, there are CGRP receptors on ganglion cells [<xref ref-type="bibr" rid="CR196">196</xref>]. Indeed, cytokines and chemokines may be released by neurons, microglia, astrocytes, macrophages and T cells, and activate pain neurons directly via activation of non-neuronal cells, depending on the expression of their receptors.</p><p id="Par55">Major cytokines have been implicated in the pathway resulting in neurogenic inflammation, including tumor necrosis factor (TNF)-&#x003b1;, IL-1&#x003b2; and IL-6 [<xref ref-type="bibr" rid="CR197">197</xref>]. TNF-&#x003b1;, a potential pain mediators in neurovascular inflammatory condition, has been suggested to be involved in the initiation and progression of a migraine attack [<xref ref-type="bibr" rid="CR198">198</xref>]. Studies have demonstrated changes in plasma, serum, or urine levels of TNF-&#x003b1; in migraine patients during attacks and attack free intervals [<xref ref-type="bibr" rid="CR199">199</xref>, <xref ref-type="bibr" rid="CR200">200</xref>]. Franceschini and coworkers reported that mRNA expression of TNF-&#x003b1; increased following migraine induction in animal models [<xref ref-type="bibr" rid="CR201">201</xref>]. Elevated TNF-&#x003b1; serum levels in humans, even in outside of attacks, confirm a possible role of TNF-&#x003b1; in migraine [<xref ref-type="bibr" rid="CR202">202</xref>]. A direct pathogenic role of TNF-&#x003b1; has not been reported during the use of this antibody in RA or MC/UC. Considering the very high prevalence of migraine, several hundred-thousand migraine patients must have received TNF-&#x003b1; antibody but there are no reports on any prevention of migraine attacks, not even in case-reports. This suggests that preventing TNF-&#x003b1; inflammation is not a viable anti-migraine target.</p><p id="Par56">Although strong and direct trigeminal stimulation causes release of CGRP and substance P which may lead to neurogenic inflammation in animal models (reviewed by [<xref ref-type="bibr" rid="CR198">198</xref>], it appears to have minor impact in acute migraine. In the line of the hypothesis that continued stimulation of both C-fibers and A&#x003b4;-fibers can cause TG inflammation and hence be implicated in chronification, this has been studied to some extent experimentally; (i) In cultured trigeminal neurons, with focus on the inflammatory pathways [<xref ref-type="bibr" rid="CR203">203</xref>, <xref ref-type="bibr" rid="CR204">204</xref>]. (ii) Administered CFA (Complete Freunds&#x02019; Adjuvant) into the temporomandibular joint (TMJ), which elicited activation of trigeminal ganglion (TG) neurons [<xref ref-type="bibr" rid="CR205">205</xref>]. (iii) Trigeminal activation using chemical stimulation of the dura mater with CFA, to test whether application of CFA on the surface of the dura mater can cause long-term activation of the TG, serving as a model of migraine chronification [<xref ref-type="bibr" rid="CR206">206</xref>] and activation of the trigeminal nucleus caudalis leading to central sensitization [<xref ref-type="bibr" rid="CR207">207</xref>].</p><p id="Par57">The above experiments suggest that inflammation indeed could activate TG. Using culture of isolated trigeminal neurons as a model for studies of neurons and glial cells, reportedly there was enhanced expression of CGRP, and of the mitogen-activated protein (MAP) kinase both in neurons and in SGCs following inflammation. The activation of a MAP kinase&#x02013;dependent inflammatory signal pathway is involved in over-expression of CGRP in nociceptive neurons and could participate in generating pain hypersensitivity [<xref ref-type="bibr" rid="CR208">208</xref>]. Looking further into in vivo inflammation, administration of CFA into the TMJ, elicits activation of TG by increased expression of pERK1/2, pp38, CaMKII, NF-&#x003ba;B and DREAM after 2 and 10&#x02009;days. Local inflammation in the TMJ, induced by CFA, results in an upstream inflammation response in the TG where the TMJ sensory fibers have their cell bodies. Interestingly, this involves both neurons and SGCs which together represent one anatomical and functional unit [<xref ref-type="bibr" rid="CR205">205</xref>].</p><p id="Par58">Local inflammation of dura mater can induce inflammatory activation in the TG. Application of inflammatory soup (IS) [<xref ref-type="bibr" rid="CR209">209</xref>, <xref ref-type="bibr" rid="CR210">210</xref>], or CFA onto the dural surface induced changes in the expression of pERK1/2, IL-1&#x003b2; and CGRP positive nerve fibers in the TG illustrating that the application of inflammatory substances onto the dura mater could be used as an animal model for long term activation of the trigeminovascular system [<xref ref-type="bibr" rid="CR206">206</xref>]. Application of CFA also induced activation (increased expression of c-Fos) of the central part of the trigemino-vascular system: the TNC and C<sub>1</sub>-C<sub>2</sub> regions of the spinal cord [<xref ref-type="bibr" rid="CR207">207</xref>]. Interestingly, the inflammation could be blocked by the administration of a kynurenic acid analogue (SZR72), precursor of a glutamatergic antagonist and an anti-inflammatory substance [<xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]. All the above evidence suggest that inflammation can be responsible for the development of at least peripheral sensitization that could then lead to the development of central sensitization.</p><p id="Par59">The concept of central sensitization is relevant not only for the development of chronic migraine, but also for the development of any chronic pain condition. Increased nociceptive processing, particularly due to the development of peripheral sensitization that could occur if indeed the trigeminal system is sustainably activated during migraine attacks, could lead to the development of central sensitization. Studies looking at biomarkers of functions of the trigeminal and autonomic systems identified important differences in the interictal state of chronic migraineurs compared to the interictal period of episodic migraineurs, suggesting a higher level of interictal activity of the trigeminal and cranial autonomic system in chronic migraineurs [<xref ref-type="bibr" rid="CR172">172</xref>]. In particular, interictal levels of CGRP and vasoactive intestinal peptide (VIP) are higher in chronic than in episodic migraine [<xref ref-type="bibr" rid="CR212">212</xref>&#x02013;<xref ref-type="bibr" rid="CR214">214</xref>]. Additionally, in animal models it has been demonstrated that chronic exposure to triptans could lead to the development of sensitization [<xref ref-type="bibr" rid="CR215">215</xref>].</p><p id="Par60">Central sensitization refers to altered behavioural of second order neurons and even of third order thalamic neurons, and is characterized by increased excitability, increase synaptic strength and enlargement of their receptive fields [<xref ref-type="bibr" rid="CR216">216</xref>&#x02013;<xref ref-type="bibr" rid="CR218">218</xref>]. Clinically, central sensitization is manifested as a state of either hyperalgesia- an exaggerated pain in response to a stimulus that normally causes mild pain, or allodynia- a pain response to a normally non painful stimulus, and exaggerated pain response referred outside the original pain site [<xref ref-type="bibr" rid="CR219">219</xref>]. These persistent sensory responses to noxious stimuli and long-lasting synaptic plasticity at spinal and supraspinal levels could be providing the neuronal basis for persistent pain and &#x0201c;pain memory&#x0201d; in chronic migraine [<xref ref-type="bibr" rid="CR220">220</xref>&#x02013;<xref ref-type="bibr" rid="CR222">222</xref>]. Central sensitization is a glutamate-dependent process and at least, NMDA receptor activation seems to be pivotal for the induction of central sensitization in neuronal fibres innervating the dura matter [<xref ref-type="bibr" rid="CR223">223</xref>].</p><p id="Par61">Indeed, during a migraine headache about 80% of migraine patients develop cutaneous allodynia, characterised by increased skin sensitivity, mostly within the referred area of pain of the ipsilateral head [<xref ref-type="bibr" rid="CR224">224</xref>, <xref ref-type="bibr" rid="CR225">225</xref>]. Stimulation of nociceptive afferent of the dura mater leads to a sensitization of second-order neurons receiving cervical input [<xref ref-type="bibr" rid="CR226">226</xref>]. About two thirds of the patients developing cutaneous allodynia report that untreated migraine attacks will result in a spread of allodynia to the other side of the head or the forearm [<xref ref-type="bibr" rid="CR224">224</xref>, <xref ref-type="bibr" rid="CR225">225</xref>], indicating the involvement of higher extra-trigeminal processes. The limb or upper body allodynia seen in migraineurs, and the extend of cutaneous allodynia could be due to the development and spread of neuronal sensitization from second order neurons in the TCC, to third order neurons in the thalamus [<xref ref-type="bibr" rid="CR219">219</xref>, <xref ref-type="bibr" rid="CR224">224</xref>]. Hence, repeated attacks of peripheral and central sensitization could lead to the development of chronic migraine.</p><p id="Par62">Central sensitization is associated with abnormal neuronal hyperexcitability in the TCC, due to an increase of the sensory inputs arriving from nociceptors on peripheral trigeminal fibres that supply the affected area, which is a consequence of peripheral sensitization [<xref ref-type="bibr" rid="CR210">210</xref>]. Topical application of inflammatory agents on the rat dura, which induces long-lasting activation of the trigeminovascular pathway [<xref ref-type="bibr" rid="CR209">209</xref>, <xref ref-type="bibr" rid="CR227">227</xref>, <xref ref-type="bibr" rid="CR228">228</xref>], provokes long lasting sensitization in trigeminocervical neurons that receive convergent inputs from the intracranial dura and extracranial periorbital skin. This neuronal sensitization is manifested as increased responsiveness to mechanical stimulation of the dura, to mechanical and thermal stimulation of the skin, and expansion of dura and cutaneous receptive fields [<xref ref-type="bibr" rid="CR209">209</xref>]. These changes are parallel to an increase of the extracellular glutamate concentration of second order neurons in the TCC [<xref ref-type="bibr" rid="CR229">229</xref>], and suggest an important contribution of glutamate and its receptors in allodynia [<xref ref-type="bibr" rid="CR229">229</xref>].</p><p id="Par63">Another factor that could contribute to the development of central sensitization and the susceptibility in developing chronic migraine could be a dysfunction in pain modulating systems. An imbalance of pain inhibition and facilitation could participate in the development or maintenance of sensitization and could contribute to the development of chronic migraine [<xref ref-type="bibr" rid="CR230">230</xref>, <xref ref-type="bibr" rid="CR231">231</xref>]. What is interesting though, is that in at least 60&#x02013;70% of patients, CM can be blocked by treatments that act peripherally at least on trigeminal fibres, such as the newly developed mAbs against the CGRP system and botulinum toxin. This further supports an important role of the trigeminal system as peripheral sensory inputs are important in sustaining central drive in CM.</p></sec></sec></sec><sec id="Sec13"><title>Conclusions</title><p id="Par64">Migraine clinical and pathophysiological mechanisms are not static and evolve continuously. During lifespan the clinical phenotype of migraine changes. These changes may include transformation from episodic to chronic migraine or even a disappearance of some or all migraine symptoms all together. Genetic and epigenetic susceptibility may be responsible for such changes, although to date, studies failed to shed any light on how such genetic alterations may be responsible for migraine pathophysiology or any evolutive mechanism. On the other hand, anatomical changes in the brain of a migraine patient exist even from early childhood, but they do not seem to have any functional consequences. The causality dilemma of whether such changes are responsible for how migraine evolves, or whether migraine mechanisms drive these anatomic changes, remains to be answered. Even in its episodic form, migraine is an evolutive condition with different mechanisms involved in the evolutive process of a migraine attack. These mechanisms include hypothalamic alterations during the premonitory phase, cortical excitability in the aura phase, activation of the ascending trigeminothalamic pain pathway with an involvement of the peripheral trigeminal arm during the headache phase, and potential cortical changes during the postdrome phase. How migraine headache is triggered following hypothalamic activation remains unknown. A potential involvement of the parasympathetic pathway is possible, as it could be influenced by hypothalamic changes and in turn activate the trigeminal system through the trigemino-autonomic arc. Such a mechanisms could explain activation of the peripheral trigeminal system from a brain-initiated event. The mechanisms that underlie the development of chronic migraine from its episodic form are not well understood. Several factors have been identified to increase the risk for migraine chronification. Inflammation and central sensitization play a significant role in the evolutive mechanisms of chronic migraine.</p><p id="Par65">The continuous changes in migraine phenotype and pathophysiology during a migraine attack between episodic and chronic migraine and during the patient lifespan, make migraine, even in its episodic form, a chronic evolutive disease.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>N/A.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Both authors contributed to the write up of this manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The APCs (article processing charges) for the articles in this thematic series &#x02018;The Changing faces of migraine&#x02019; were made possible through independent educational sponsorship by Eli Lilly. Eli Lilly provided the funds through an educational grant which included enduring materials within the context of a symposium at the 12th European Headache Federation Congress in September 2018, chaired by Paolo Martelletti. This grant was provided to Springer Healthcare IME who organized the symposium and all of the enduring materials. Three of the articles in this thematic series were developed from content presented at the symposium. Eli Lilly were not involved in the planning of the thematic series, the selection process for topics, nor in any peer review or decision-making processes. The articles have undergone the journal&#x02019;s standard peer review process overseen by the Editor-in-Chief. For articles where the Editor-in-Chief is an author, the peer review process was overseen by one of the other Editors responsible for this thematic series.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>N/A.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par66">N/A.</p></notes><notes><title>Consent for publication</title><p id="Par67">Both authors consent for publication.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par68">N/A.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>TJ</given-names></name><name><surname>Scher</surname><given-names>AI</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Kolodner</surname><given-names>K</given-names></name><name><surname>Liberman</surname><given-names>J</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity</article-title><source>Cephalalgia.</source><year>2003</year><volume>23</volume><issue>7</issue><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.2003.00568.x</pub-id><?supplied-pmid 12950377?><pub-id pub-id-type="pmid">12950377</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srikiatkhachorn</surname><given-names>A</given-names></name><name><surname>Phanthumchinda</surname><given-names>K</given-names></name></person-group><article-title>Prevalence and clinical features of chronic daily headache in a headache clinic</article-title><source>Headache.</source><year>1997</year><volume>37</volume><issue>5</issue><fpage>277</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.1997.3705277.x</pub-id><?supplied-pmid 9195765?><pub-id pub-id-type="pmid">9195765</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karbowniczek</surname><given-names>A</given-names></name><name><surname>Domitrz</surname><given-names>I</given-names></name></person-group><article-title>Frequency and clinical characteristics of chronic daily headache in an outpatient clinic setting</article-title><source>Neurol Neurochir Pol</source><year>2011</year><volume>45</volume><issue>1</issue><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/S0028-3843(14)60054-2</pub-id><?supplied-pmid 21384288?><pub-id pub-id-type="pmid">21384288</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Diamond</surname><given-names>M</given-names></name><name><surname>Freitag</surname><given-names>F</given-names></name><name><surname>Reed</surname><given-names>ML</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><etal/></person-group><article-title>Migraine prevalence, disease burden, and the need for preventive therapy</article-title><source>Neurology.</source><year>2007</year><volume>68</volume><issue>5</issue><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000252808.97649.21</pub-id><?supplied-pmid 17261680?><pub-id pub-id-type="pmid">17261680</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>The global burden of disease</source><year>2004</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozge</surname><given-names>A</given-names></name><name><surname>Abu-Arafeh</surname><given-names>I</given-names></name><name><surname>Gelfand</surname><given-names>AA</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Cuvellier</surname><given-names>JC</given-names></name><name><surname>Valeriani</surname><given-names>M</given-names></name><etal/></person-group><article-title>Experts&#x02019; opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta</article-title><source>J Headache Pain</source><year>2017</year><volume>18</volume><issue>1</issue><fpage>113</fpage><pub-id pub-id-type="doi">10.1186/s10194-017-0819-x</pub-id><?supplied-pmid 29285571?><pub-id pub-id-type="pmid">29285571</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annequin</surname><given-names>D</given-names></name><name><surname>Tourniaire</surname><given-names>B</given-names></name><name><surname>Massiou</surname><given-names>H</given-names></name></person-group><article-title>Migraine and headache in childhood and adolescence</article-title><source>Pediatr Clin N Am</source><year>2000</year><volume>47</volume><issue>3</issue><fpage>617</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/S0031-3955(05)70229-7</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Peres</surname><given-names>FM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Silberstein</surname><given-names>SD</given-names></name><name><surname>Stiles</surname><given-names>MA</given-names></name><name><surname>Young</surname><given-names>WB</given-names></name></person-group><article-title>Epidemiology of migraine</article-title><source>Atlas of migraine and other headaches</source><year>2005</year><edition>2</edition><publisher-loc>London and New York</publisher-loc><publisher-name>Taylor &#x00026; Francis</publisher-name><fpage>41</fpage><lpage>49</lpage></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>MB</given-names></name><name><surname>Rasmussen</surname><given-names>BK</given-names></name><name><surname>Thorvaldsen</surname><given-names>P</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name></person-group><article-title>Prevalence and sex-ratio of the subtypes of migraine</article-title><source>Int J Epidemiol</source><year>1995</year><volume>24</volume><issue>3</issue><fpage>612</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1093/ije/24.3.612</pub-id><?supplied-pmid 7672904?><pub-id pub-id-type="pmid">7672904</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>SD</given-names></name><name><surname>Merriam</surname><given-names>GR</given-names></name></person-group><article-title>Estrogens, progestins, and headache</article-title><source>Neurology.</source><year>1991</year><volume>41</volume><issue>6</issue><fpage>786</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1212/WNL.41.6.786</pub-id><?supplied-pmid 2046918?><pub-id pub-id-type="pmid">2046918</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neri</surname><given-names>I</given-names></name><name><surname>Granella</surname><given-names>F</given-names></name><name><surname>Nappi</surname><given-names>R</given-names></name><name><surname>Manzoni</surname><given-names>GC</given-names></name><name><surname>Facchinetti</surname><given-names>F</given-names></name><name><surname>Genazzani</surname><given-names>AR</given-names></name></person-group><article-title>Characteristics of headache at menopause: a clinico-epidemiologic study</article-title><source>Maturitas.</source><year>1993</year><volume>17</volume><issue>1</issue><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/0378-5122(93)90121-W</pub-id><?supplied-pmid 8412841?><pub-id pub-id-type="pmid">8412841</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fettes</surname><given-names>I</given-names></name></person-group><article-title>Migraine in the menopause</article-title><source>Neurology.</source><year>1999</year><volume>53</volume><issue>4 Suppl 1</issue><fpage>S29</fpage><lpage>S33</lpage><?supplied-pmid 10487511?><pub-id pub-id-type="pmid">10487511</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffenrath</surname><given-names>V</given-names></name><name><surname>Fendrich</surname><given-names>K</given-names></name><name><surname>Vennemann</surname><given-names>M</given-names></name><name><surname>Meisinger</surname><given-names>C</given-names></name><name><surname>Ladwig</surname><given-names>KH</given-names></name><name><surname>Evers</surname><given-names>S</given-names></name><etal/></person-group><article-title>Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG headache study</article-title><source>Cephalalgia.</source><year>2009</year><volume>29</volume><issue>1</issue><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01699.x</pub-id><?supplied-pmid 18771491?><pub-id pub-id-type="pmid">18771491</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwaiger</surname><given-names>J</given-names></name><name><surname>Kiechl</surname><given-names>S</given-names></name><name><surname>Seppi</surname><given-names>K</given-names></name><name><surname>Sawires</surname><given-names>M</given-names></name><name><surname>Stockner</surname><given-names>H</given-names></name><name><surname>Erlacher</surname><given-names>T</given-names></name><etal/></person-group><article-title>Prevalence of primary headaches and cranial neuralgias in men and women aged 55-94 years (Bruneck study)</article-title><source>Cephalalgia.</source><year>2009</year><volume>29</volume><issue>2</issue><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01705.x</pub-id><?supplied-pmid 18823362?><pub-id pub-id-type="pmid">18823362</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maytal</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>M</given-names></name><name><surname>Shechter</surname><given-names>A</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Pediatric migraine and the international headache society (IHS) criteria</article-title><source>Neurology.</source><year>1997</year><volume>48</volume><issue>3</issue><fpage>602</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1212/WNL.48.3.602</pub-id><?supplied-pmid 9065533?><pub-id pub-id-type="pmid">9065533</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eidlitz-Markus</surname><given-names>T</given-names></name><name><surname>Gorali</surname><given-names>O</given-names></name><name><surname>Haimi-Cohen</surname><given-names>Y</given-names></name><name><surname>Zeharia</surname><given-names>A</given-names></name></person-group><article-title>Symptoms of migraine in the paediatric population by age group</article-title><source>Cephalalgia.</source><year>2008</year><volume>28</volume><issue>12</issue><fpage>1259</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01668.x</pub-id><?supplied-pmid 18727643?><pub-id pub-id-type="pmid">18727643</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelfand</surname><given-names>AA</given-names></name><name><surname>Reider</surname><given-names>AC</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Cranial autonomic symptoms in pediatric migraine are the rule, not the exception</article-title><source>Neurology.</source><year>2013</year><volume>81</volume><issue>5</issue><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31829d872a</pub-id><?supplied-pmid 23897870?><pub-id pub-id-type="pmid">23897870</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straube</surname><given-names>A</given-names></name><name><surname>Andreou</surname><given-names>A</given-names></name></person-group><article-title>Primary headaches during lifespan</article-title><source>J Headache Pain</source><year>2019</year><volume>20</volume><issue>1</issue><fpage>35</fpage><pub-id pub-id-type="doi">10.1186/s10194-019-0985-0</pub-id><?supplied-pmid 30961531?><pub-id pub-id-type="pmid">30961531</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname><given-names>EJ</given-names></name><name><surname>Van Baal</surname><given-names>C</given-names></name><name><surname>Gaist</surname><given-names>D</given-names></name><name><surname>Kallela</surname><given-names>M</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Svensson</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Genetic and environmental influences on migraine: a twin study across six countries</article-title><source>Twin Res</source><year>2003</year><volume>6</volume><issue>5</issue><fpage>422</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1375/136905203770326420</pub-id><?supplied-pmid 14624726?><pub-id pub-id-type="pmid">14624726</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Maagdenberg</surname><given-names>A</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name></person-group><article-title>Novel hypotheses emerging from GWAS in migraine?</article-title><source>J Headache Pain</source><year>2019</year><volume>20</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s10194-018-0956-x</pub-id><?supplied-pmid 30634909?><pub-id pub-id-type="pmid">30634909</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name><name><surname>Smoller</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>PH</given-names></name></person-group><article-title>Statistical power and utility of meta-analysis methods for cross-phenotype genome-wide association studies</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><issue>3</issue><fpage>e0193256</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0193256</pub-id><?supplied-pmid 29494641?><pub-id pub-id-type="pmid">29494641</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><etal/></person-group><article-title>10 years of GWAS discovery: biology, function, and translation</article-title><source>Am J Hum Genet</source><year>2017</year><volume>101</volume><issue>1</issue><fpage>5</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.06.005</pub-id><?supplied-pmid 28686856?><pub-id pub-id-type="pmid">28686856</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gormley</surname><given-names>P</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name><name><surname>Winsvold</surname><given-names>BS</given-names></name><name><surname>Palta</surname><given-names>P</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><etal/></person-group><article-title>Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine</article-title><source>Nat Genet</source><year>2016</year><volume>48</volume><issue>8</issue><fpage>856</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1038/ng.3598</pub-id><?supplied-pmid 27322543?><pub-id pub-id-type="pmid">27322543</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>MD</given-names></name><name><surname>Klever</surname><given-names>RR</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>Ayata</surname><given-names>C</given-names></name><name><surname>van den Maagdenberg</surname><given-names>AM</given-names></name></person-group><article-title>Migraine pathophysiology: lessons from mouse models and human genetics</article-title><source>Lancet Neurol</source><year>2015</year><volume>14</volume><issue>1</issue><fpage>65</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(14)70220-0</pub-id><?supplied-pmid 25496898?><pub-id pub-id-type="pmid">25496898</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneggenburger</surname><given-names>R</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><article-title>Presynaptic calcium and control of vesicle fusion</article-title><source>Curr Opin Neurobiol</source><year>2005</year><volume>15</volume><issue>3</issue><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2005.05.006</pub-id><?supplied-pmid 15919191?><pub-id pub-id-type="pmid">15919191</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Fusco</surname><given-names>M</given-names></name><name><surname>Marconi</surname><given-names>R</given-names></name><name><surname>Silvestri</surname><given-names>L</given-names></name><name><surname>Atorino</surname><given-names>L</given-names></name><name><surname>Rampoldi</surname><given-names>L</given-names></name><name><surname>Morgante</surname><given-names>L</given-names></name><etal/></person-group><article-title>Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2</article-title><source>Nat Genet</source><year>2003</year><volume>33</volume><issue>2</issue><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/ng1081</pub-id><?supplied-pmid 12539047?><pub-id pub-id-type="pmid">12539047</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dichgans</surname><given-names>M</given-names></name><name><surname>Freilinger</surname><given-names>T</given-names></name><name><surname>Eckstein</surname><given-names>G</given-names></name><name><surname>Babini</surname><given-names>E</given-names></name><name><surname>Lorenz-Depiereux</surname><given-names>B</given-names></name><name><surname>Biskup</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine</article-title><source>Lancet.</source><year>2005</year><volume>366</volume><issue>9483</issue><fpage>371</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(05)66786-4</pub-id><?supplied-pmid 16054936?><pub-id pub-id-type="pmid">16054936</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Maagdenberg</surname><given-names>AM</given-names></name><name><surname>Pietrobon</surname><given-names>D</given-names></name><name><surname>Pizzorusso</surname><given-names>T</given-names></name><name><surname>Kaja</surname><given-names>S</given-names></name><name><surname>Broos</surname><given-names>LA</given-names></name><name><surname>Cesetti</surname><given-names>T</given-names></name><etal/></person-group><article-title>A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression</article-title><source>Neuron.</source><year>2004</year><volume>41</volume><issue>5</issue><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(04)00085-6</pub-id><?supplied-pmid 15003170?><pub-id pub-id-type="pmid">15003170</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessman</surname><given-names>M</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>Kaunisto</surname><given-names>MA</given-names></name><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>Ophoff</surname><given-names>RA</given-names></name></person-group><article-title>Migraine: a complex genetic disorder</article-title><source>Lancet Neurol</source><year>2007</year><volume>6</volume><issue>6</issue><fpage>521</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(07)70126-6</pub-id><?supplied-pmid 17509487?><pub-id pub-id-type="pmid">17509487</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Moon</surname><given-names>H</given-names></name><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Lasalandra</surname><given-names>MP</given-names></name><name><surname>Andreou</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein study</article-title><source>Neurobiol Dis</source><year>2014</year><volume>64</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2013.12.004</pub-id><?supplied-pmid 24355314?><pub-id pub-id-type="pmid">24355314</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>R</given-names></name><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Chami</surname><given-names>L</given-names></name><name><surname>Bergerot</surname><given-names>A</given-names></name><name><surname>van den Maagdenberg</surname><given-names>A</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse</article-title><source>Cephalalgia.</source><year>2011</year><volume>31</volume><issue>13</issue><fpage>1368</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1177/0333102411418847</pub-id><?supplied-pmid 21893556?><pub-id pub-id-type="pmid">21893556</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerring</surname><given-names>ZF</given-names></name><name><surname>McRae</surname><given-names>AF</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name></person-group><article-title>Genome-wide DNA methylation profiling in whole blood reveals epigenetic signatures associated with migraine</article-title><source>BMC Genomics</source><year>2018</year><volume>19</volume><issue>1</issue><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/s12864-018-4450-2</pub-id><?supplied-pmid 29357833?><pub-id pub-id-type="pmid">29357833</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terlizzi</surname><given-names>R</given-names></name><name><surname>Bacalini</surname><given-names>MG</given-names></name><name><surname>Pirazzini</surname><given-names>C</given-names></name><name><surname>Giannini</surname><given-names>G</given-names></name><name><surname>Pierangeli</surname><given-names>G</given-names></name><name><surname>Garagnani</surname><given-names>P</given-names></name><etal/></person-group><article-title>Epigenetic DNA methylation changes in episodic and chronic migraine</article-title><source>Neurol Sci</source><year>2018</year><volume>39</volume><issue>Suppl 1</issue><fpage>67</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1007/s10072-018-3348-8</pub-id><?supplied-pmid 29904847?><pub-id pub-id-type="pmid">29904847</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurth</surname><given-names>T</given-names></name><name><surname>Mohamed</surname><given-names>S</given-names></name><name><surname>Maillard</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>YC</given-names></name><name><surname>Chabriat</surname><given-names>H</given-names></name><name><surname>Mazoyer</surname><given-names>B</given-names></name><etal/></person-group><article-title>Headache, migraine, and structural brain lesions and function: population based epidemiology of vascular ageing-MRI study</article-title><source>BMJ.</source><year>2011</year><volume>342</volume><fpage>c7357</fpage><pub-id pub-id-type="doi">10.1136/bmj.c7357</pub-id><?supplied-pmid 21245119?><pub-id pub-id-type="pmid">21245119</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruit</surname><given-names>MC</given-names></name><name><surname>van Buchem</surname><given-names>MA</given-names></name><name><surname>Hofman</surname><given-names>PA</given-names></name><name><surname>Bakkers</surname><given-names>JT</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Migraine as a risk factor for subclinical brain lesions</article-title><source>JAMA.</source><year>2004</year><volume>291</volume><issue>4</issue><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1001/jama.291.4.427</pub-id><?supplied-pmid 14747499?><pub-id pub-id-type="pmid">14747499</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruit</surname><given-names>MC</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><name><surname>van Buchem</surname><given-names>MA</given-names></name></person-group><article-title>Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study</article-title><source>Brain.</source><year>2005</year><volume>128</volume><issue>Pt 9</issue><fpage>2068</fpage><lpage>2077</lpage><pub-id pub-id-type="doi">10.1093/brain/awh542</pub-id><?supplied-pmid 16006538?><pub-id pub-id-type="pmid">16006538</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arkink</surname><given-names>EB</given-names></name><name><surname>Palm-Meinders</surname><given-names>IH</given-names></name><name><surname>Koppen</surname><given-names>H</given-names></name><name><surname>Milles</surname><given-names>J</given-names></name><name><surname>van Lew</surname><given-names>B</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Microstructural white matter changes preceding white matter hyperintensities in migraine</article-title><source>Neurology</source><year>2019</year><volume>93</volume><issue>7</issue><fpage>e688</fpage><lpage>e694</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000007940</pub-id><?supplied-pmid 31296653?><pub-id pub-id-type="pmid">31296653</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palm-Meinders</surname><given-names>IH</given-names></name><name><surname>Koppen</surname><given-names>H</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Konishi</surname><given-names>J</given-names></name><name><surname>Moonen</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Structural brain changes in migraine</article-title><source>JAMA.</source><year>2012</year><volume>308</volume><issue>18</issue><fpage>1889</fpage><lpage>1897</lpage><pub-id pub-id-type="doi">10.1001/jama.2012.14276</pub-id><?supplied-pmid 23150008?><pub-id pub-id-type="pmid">23150008</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamedani</surname><given-names>AG</given-names></name><name><surname>Rose</surname><given-names>KM</given-names></name><name><surname>Peterlin</surname><given-names>BL</given-names></name><name><surname>Mosley</surname><given-names>TH</given-names></name><name><surname>Coker</surname><given-names>LH</given-names></name><name><surname>Jack</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Migraine and white matter hyperintensities: the ARIC MRI study</article-title><source>Neurology.</source><year>2013</year><volume>81</volume><issue>15</issue><fpage>1308</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a8235b</pub-id><?supplied-pmid 23975874?><pub-id pub-id-type="pmid">23975874</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schick</surname><given-names>S</given-names></name><name><surname>Gahleitner</surname><given-names>A</given-names></name><name><surname>Wober-Bingol</surname><given-names>C</given-names></name><name><surname>Wober</surname><given-names>C</given-names></name><name><surname>Ba-Ssalamah</surname><given-names>A</given-names></name><name><surname>Schoder</surname><given-names>M</given-names></name><etal/></person-group><article-title>Virchow-Robin spaces in childhood migraine</article-title><source>Neuroradiology.</source><year>1999</year><volume>41</volume><issue>4</issue><fpage>283</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1007/s002340050749</pub-id><?supplied-pmid 10344516?><pub-id pub-id-type="pmid">10344516</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behzadmehr</surname><given-names>R</given-names></name><name><surname>Arefi</surname><given-names>S</given-names></name><name><surname>Behzadmehr</surname><given-names>R</given-names></name></person-group><article-title>Brain imaging findings in children with headache</article-title><source>Acta Inform Med</source><year>2018</year><volume>26</volume><issue>1</issue><fpage>51</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.5455/aim.2018.26.51-53</pub-id><?supplied-pmid 29719314?><pub-id pub-id-type="pmid">29719314</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwedt</surname><given-names>TJ</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Rothner</surname><given-names>AD</given-names></name></person-group><article-title>&#x0201c;Benign&#x0201d; imaging abnormalities in children and adolescents with headache</article-title><source>Headache.</source><year>2006</year><volume>46</volume><issue>3</issue><fpage>387</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00371.x</pub-id><?supplied-pmid 16618255?><pub-id pub-id-type="pmid">16618255</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashir</surname><given-names>A</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Ashina</surname><given-names>S</given-names></name><name><surname>Ashina</surname><given-names>M</given-names></name></person-group><article-title>Migraine and structural changes in the brain: a systematic review and meta-analysis</article-title><source>Neurology.</source><year>2013</year><volume>81</volume><issue>14</issue><fpage>1260</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a6cb32</pub-id><?supplied-pmid 23986301?><pub-id pub-id-type="pmid">23986301</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name></person-group><article-title>Grey matter alterations in migraine: a systematic review and meta-analysis</article-title><source>Neuroimage Clin</source><year>2017</year><volume>14</volume><fpage>130</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.nicl.2017.01.019</pub-id><?supplied-pmid 28180071?><pub-id pub-id-type="pmid">28180071</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demir</surname><given-names>BT</given-names></name><name><surname>Bayram</surname><given-names>NA</given-names></name><name><surname>Ayturk</surname><given-names>Z</given-names></name><name><surname>Erdamar</surname><given-names>H</given-names></name><name><surname>Seven</surname><given-names>P</given-names></name><name><surname>Calp</surname><given-names>A</given-names></name><etal/></person-group><article-title>Structural changes in the cerebrum, cerebellum and Corpus callosum in migraine patients</article-title><source>Clin Invest Med</source><year>2016</year><volume>39</volume><issue>6</issue><fpage>27495</fpage><pub-id pub-id-type="doi">10.25011/cim.v39i6.27495</pub-id><?supplied-pmid 27917786?><pub-id pub-id-type="pmid">27917786</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hougaard</surname><given-names>A</given-names></name><name><surname>Amin</surname><given-names>FM</given-names></name><name><surname>Ashina</surname><given-names>M</given-names></name></person-group><article-title>Migraine and structural abnormalities in the brain</article-title><source>Curr Opin Neurol</source><year>2014</year><volume>27</volume><issue>3</issue><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1097/WCO.0000000000000086</pub-id><?supplied-pmid 24751961?><pub-id pub-id-type="pmid">24751961</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>CD</given-names></name><name><surname>Gaw</surname><given-names>N</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Schwedt</surname><given-names>TJ</given-names></name></person-group><article-title>Migraine classification using magnetic resonance imaging resting-state functional connectivity data</article-title><source>Cephalalgia.</source><year>2017</year><volume>37</volume><issue>9</issue><fpage>828</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1177/0333102416652091</pub-id><?supplied-pmid 27306407?><pub-id pub-id-type="pmid">27306407</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili-Nezhad</surname><given-names>S</given-names></name><name><surname>Sedghi</surname><given-names>A</given-names></name><name><surname>Schweser</surname><given-names>F</given-names></name><name><surname>Eslami Shahr Babaki</surname><given-names>A</given-names></name><name><surname>Jahanshad</surname><given-names>N</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Structural and functional reorganization of the brain in migraine without aura</article-title><source>Front Neurol</source><year>2019</year><volume>10</volume><fpage>442</fpage><pub-id pub-id-type="doi">10.3389/fneur.2019.00442</pub-id><?supplied-pmid 31133962?><pub-id pub-id-type="pmid">31133962</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DaSilva</surname><given-names>AF</given-names></name><name><surname>Granziera</surname><given-names>C</given-names></name><name><surname>Snyder</surname><given-names>J</given-names></name><name><surname>Hadjikhani</surname><given-names>N</given-names></name></person-group><article-title>Thickening in the somatosensory cortex of patients with migraine</article-title><source>Neurology.</source><year>2007</year><volume>69</volume><issue>21</issue><fpage>1990</fpage><lpage>1995</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000291618.32247.2d</pub-id><?supplied-pmid 18025393?><pub-id pub-id-type="pmid">18025393</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Suh</surname><given-names>SI</given-names></name><name><surname>Seol</surname><given-names>HY</given-names></name><name><surname>Oh</surname><given-names>K</given-names></name><name><surname>Seo</surname><given-names>WK</given-names></name><name><surname>Yu</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Regional grey matter changes in patients with migraine: a voxel-based morphometry study</article-title><source>Cephalalgia.</source><year>2008</year><volume>28</volume><issue>6</issue><fpage>598</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01550.x</pub-id><?supplied-pmid 18422725?><pub-id pub-id-type="pmid">18422725</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>R</given-names></name><name><surname>Rocca</surname><given-names>MA</given-names></name><name><surname>Colombo</surname><given-names>B</given-names></name><name><surname>Valsasina</surname><given-names>P</given-names></name><name><surname>Horsfield</surname><given-names>MA</given-names></name><name><surname>Copetti</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cortical abnormalities in patients with migraine: a surface-based analysis</article-title><source>Radiology.</source><year>2013</year><volume>268</volume><issue>1</issue><fpage>170</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1148/radiol.13122004</pub-id><?supplied-pmid 23533286?><pub-id pub-id-type="pmid">23533286</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt-Wilcke</surname><given-names>T</given-names></name><name><surname>Ganssbauer</surname><given-names>S</given-names></name><name><surname>Neuner</surname><given-names>T</given-names></name><name><surname>Bogdahn</surname><given-names>U</given-names></name><name><surname>May</surname><given-names>A</given-names></name></person-group><article-title>Subtle grey matter changes between migraine patients and healthy controls</article-title><source>Cephalalgia.</source><year>2008</year><volume>28</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2007.01428.x</pub-id><?supplied-pmid 17986275?><pub-id pub-id-type="pmid">17986275</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mainero</surname><given-names>Caterina</given-names></name><name><surname>Boshyan</surname><given-names>Jasmine</given-names></name><name><surname>Hadjikhani</surname><given-names>Nouchine</given-names></name></person-group><article-title>Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine</article-title><source>Annals of Neurology</source><year>2011</year><volume>70</volume><issue>5</issue><fpage>838</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1002/ana.22537</pub-id><?supplied-pmid 22162064?><pub-id pub-id-type="pmid">22162064</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magon</surname><given-names>S</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Stankewitz</surname><given-names>A</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Schankin</surname><given-names>C</given-names></name><name><surname>Ashina</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cortical abnormalities in episodic migraine: a multi-center 3T MRI study</article-title><source>Cephalalgia.</source><year>2019</year><volume>39</volume><issue>5</issue><fpage>665</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1177/0333102418795163</pub-id><?supplied-pmid 30525946?><pub-id pub-id-type="pmid">30525946</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magon</surname><given-names>S</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Stankewitz</surname><given-names>A</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Tso</surname><given-names>AR</given-names></name><name><surname>Ashina</surname><given-names>M</given-names></name><etal/></person-group><article-title>Morphological abnormalities of thalamic subnuclei in migraine: a multicenter MRI study at 3 tesla</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><issue>40</issue><fpage>13800</fpage><lpage>13806</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2154-15.2015</pub-id><?supplied-pmid 26446230?><pub-id pub-id-type="pmid">26446230</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granziera</surname><given-names>C</given-names></name><name><surname>Daducci</surname><given-names>A</given-names></name><name><surname>Romascano</surname><given-names>D</given-names></name><name><surname>Roche</surname><given-names>A</given-names></name><name><surname>Helms</surname><given-names>G</given-names></name><name><surname>Krueger</surname><given-names>G</given-names></name><etal/></person-group><article-title>Structural abnormalities in the thalamus of migraineurs with aura: a multiparametric study at 3 T</article-title><source>Hum Brain Mapp</source><year>2014</year><volume>35</volume><issue>4</issue><fpage>1461</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1002/hbm.22266</pub-id><?supplied-pmid 23450507?><pub-id pub-id-type="pmid">23450507</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>CD</given-names></name><name><surname>Plasencia</surname><given-names>JD</given-names></name><name><surname>Frakes</surname><given-names>DH</given-names></name><name><surname>Schwedt</surname><given-names>TJ</given-names></name></person-group><article-title>Structural alterations of the brainstem in migraine</article-title><source>Neuroimage Clin</source><year>2017</year><volume>13</volume><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.nicl.2016.10.023</pub-id><?supplied-pmid 28003961?><pub-id pub-id-type="pmid">28003961</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Di Renzo</surname><given-names>A</given-names></name><name><surname>Tinelli</surname><given-names>E</given-names></name><name><surname>Iacovelli</surname><given-names>E</given-names></name><name><surname>Lepre</surname><given-names>C</given-names></name><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Evidence for brain morphometric changes during the migraine cycle: a magnetic resonance-based morphometry study</article-title><source>Cephalalgia.</source><year>2015</year><volume>35</volume><issue>9</issue><fpage>783</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1177/0333102414559732</pub-id><?supplied-pmid 25414472?><pub-id pub-id-type="pmid">25414472</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilgic</surname><given-names>B</given-names></name><name><surname>Kocaman</surname><given-names>G</given-names></name><name><surname>Arslan</surname><given-names>AB</given-names></name><name><surname>Noyan</surname><given-names>H</given-names></name><name><surname>Sherifov</surname><given-names>R</given-names></name><name><surname>Alkan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Volumetric differences suggest involvement of cerebellum and brainstem in chronic migraine</article-title><source>Cephalalgia.</source><year>2016</year><volume>36</volume><issue>4</issue><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1177/0333102415588328</pub-id><?supplied-pmid 26002699?><pub-id pub-id-type="pmid">26002699</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neeb</surname><given-names>L</given-names></name><name><surname>Bastian</surname><given-names>K</given-names></name><name><surname>Villringer</surname><given-names>K</given-names></name><name><surname>Israel</surname><given-names>H</given-names></name><name><surname>Reuter</surname><given-names>U</given-names></name><name><surname>Fiebach</surname><given-names>JB</given-names></name></person-group><article-title>Structural gray matter alterations in chronic migraine: implications for a progressive disease?</article-title><source>Headache.</source><year>2017</year><volume>57</volume><issue>3</issue><fpage>400</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1111/head.13012</pub-id><?supplied-pmid 28028808?><pub-id pub-id-type="pmid">28028808</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Petolicchio</surname><given-names>B</given-names></name><name><surname>Di Renzo</surname><given-names>A</given-names></name><name><surname>Tinelli</surname><given-names>E</given-names></name><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Parisi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Cerebral gray matter volume in patients with chronic migraine: correlations with clinical features</article-title><source>J Headache Pain</source><year>2017</year><volume>18</volume><issue>1</issue><fpage>115</fpage><pub-id pub-id-type="doi">10.1186/s10194-017-0825-z</pub-id><?supplied-pmid 29322264?><pub-id pub-id-type="pmid">29322264</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name></person-group><article-title>Volume of hypothalamus as a diagnostic biomarker of chronic migraine</article-title><source>Front Neurol</source><year>2019</year><volume>10</volume><fpage>606</fpage><pub-id pub-id-type="doi">10.3389/fneur.2019.00606</pub-id><?supplied-pmid 31244765?><pub-id pub-id-type="pmid">31244765</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocca</surname><given-names>MA</given-names></name><name><surname>Messina</surname><given-names>R</given-names></name><name><surname>Colombo</surname><given-names>B</given-names></name><name><surname>Falini</surname><given-names>A</given-names></name><name><surname>Comi</surname><given-names>G</given-names></name><name><surname>Filippi</surname><given-names>M</given-names></name></person-group><article-title>Structural brain MRI abnormalities in pediatric patients with migraine</article-title><source>J Neurol</source><year>2014</year><volume>261</volume><issue>2</issue><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1007/s00415-013-7201-y</pub-id><?supplied-pmid 24305994?><pub-id pub-id-type="pmid">24305994</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>JD</given-names></name><name><surname>Forkert</surname><given-names>ND</given-names></name><name><surname>Yang</surname><given-names>QZ</given-names></name><name><surname>Pavitt</surname><given-names>S</given-names></name><name><surname>MacEachern</surname><given-names>SJ</given-names></name><name><surname>Moseley</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Brain diffusion abnormalities in children with tension-type and migraine-type headaches</article-title><source>AJNR Am J Neuroradiol</source><year>2018</year><volume>39</volume><issue>5</issue><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.3174/ajnr.A5582</pub-id><?supplied-pmid 29545251?><pub-id pub-id-type="pmid">29545251</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>A</given-names></name></person-group><article-title>Experience-dependent structural plasticity in the adult human brain</article-title><source>Trends Cogn Sci</source><year>2011</year><volume>15</volume><issue>10</issue><fpage>475</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.tics.2011.08.002</pub-id><?supplied-pmid 21906988?><pub-id pub-id-type="pmid">21906988</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurell</surname><given-names>K</given-names></name><name><surname>Artto</surname><given-names>V</given-names></name><name><surname>Bendtsen</surname><given-names>L</given-names></name><name><surname>Hagen</surname><given-names>K</given-names></name><name><surname>Haggstrom</surname><given-names>J</given-names></name><name><surname>Linde</surname><given-names>M</given-names></name><etal/></person-group><article-title>Premonitory symptoms in migraine: a cross-sectional study in 2714 persons</article-title><source>Cephalalgia.</source><year>2016</year><volume>36</volume><issue>10</issue><fpage>951</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1177/0333102415620251</pub-id><?supplied-pmid 26643378?><pub-id pub-id-type="pmid">26643378</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Kong</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group><article-title>International classification of headache disorders 3rd edition beta-based field testing of vestibular migraine in China: demographic, clinical characteristics, audiometric findings and diagnosis statues</article-title><source>Cephalalgia.</source><year>2016</year><volume>36</volume><issue>3</issue><fpage>240</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1177/0333102415587704</pub-id><?supplied-pmid 25986149?><pub-id pub-id-type="pmid">25986149</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1&#x02013;211. 10.1177/0333102417738202</mixed-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giffin</surname><given-names>NJ</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Silberstein</surname><given-names>SD</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>The migraine postdrome: an electronic diary study</article-title><source>Neurology.</source><year>2016</year><volume>87</volume><issue>3</issue><fpage>309</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000002789</pub-id><?supplied-pmid 27335112?><pub-id pub-id-type="pmid">27335112</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelman</surname><given-names>L</given-names></name></person-group><article-title>The triggers or precipitants of the acute migraine attack</article-title><source>Cephalalgia.</source><year>2007</year><volume>27</volume><issue>5</issue><fpage>394</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2007.01303.x</pub-id><?supplied-pmid 17403039?><pub-id pub-id-type="pmid">17403039</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>P</given-names></name><name><surname>Charbit</surname><given-names>A</given-names></name><name><surname>Andreou</surname><given-names>A</given-names></name><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Holland</surname><given-names>P</given-names></name></person-group><article-title>Neurobiology of migraine</article-title><source>Neuroscience.</source><year>2009</year><volume>161</volume><issue>2</issue><fpage>327</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.03.019</pub-id><?supplied-pmid 19303917?><pub-id pub-id-type="pmid">19303917</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambru</surname><given-names>G</given-names></name><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Guglielmetti</surname><given-names>M</given-names></name><name><surname>Martelletti</surname><given-names>P</given-names></name></person-group><article-title>Emerging drugs for migraine treatment: an update</article-title><source>Expert Opin Emerg Drugs</source><year>2018</year><volume>23</volume><issue>4</issue><fpage>301</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1080/14728214.2018.1552939</pub-id><?supplied-pmid 30484333?><pub-id pub-id-type="pmid">30484333</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toni</surname><given-names>R</given-names></name><name><surname>Malaguti</surname><given-names>A</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Martini</surname><given-names>L</given-names></name></person-group><article-title>The human hypothalamus: a morpho-functional perspective</article-title><source>J Endocrinol Investig</source><year>2004</year><volume>27</volume><issue>6 Suppl</issue><fpage>73</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">15481807</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alstadhaug</surname><given-names>KB</given-names></name><name><surname>Bekkelund</surname><given-names>S</given-names></name><name><surname>Salvesen</surname><given-names>R</given-names></name></person-group><article-title>Circannual periodicity of migraine?</article-title><source>Eur J Neurol</source><year>2007</year><volume>14</volume><issue>9</issue><fpage>983</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1331.2007.01828.x</pub-id><?supplied-pmid 17718689?><pub-id pub-id-type="pmid">17718689</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alstadhaug</surname><given-names>KB</given-names></name><name><surname>Salvesen</surname><given-names>R</given-names></name><name><surname>Bekkelund</surname><given-names>SI</given-names></name></person-group><article-title>Seasonal variation in migraine</article-title><source>Cephalalgia.</source><year>2005</year><volume>25</volume><issue>10</issue><fpage>811</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2005.01018.x</pub-id><?supplied-pmid 16162258?><pub-id pub-id-type="pmid">16162258</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Chee</surname><given-names>E</given-names></name><name><surname>Sawyer</surname><given-names>J</given-names></name><name><surname>Silberstein</surname><given-names>SD</given-names></name></person-group><article-title>Menstrual cycle and headache in a population sample of migraineurs</article-title><source>Neurology.</source><year>2000</year><volume>55</volume><issue>10</issue><fpage>1517</fpage><lpage>1523</lpage><pub-id pub-id-type="doi">10.1212/WNL.55.10.1517</pub-id><?supplied-pmid 11094107?><pub-id pub-id-type="pmid">11094107</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denuelle</surname><given-names>M</given-names></name><name><surname>Fabre</surname><given-names>N</given-names></name><name><surname>Payoux</surname><given-names>P</given-names></name><name><surname>Chollet</surname><given-names>F</given-names></name><name><surname>Geraud</surname><given-names>G</given-names></name></person-group><article-title>Hypothalamic activation in spontaneous migraine attacks</article-title><source>Headache.</source><year>2007</year><volume>47</volume><issue>10</issue><fpage>1418</fpage><lpage>1426</lpage><?supplied-pmid 18052951?><pub-id pub-id-type="pmid">18052951</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte</surname><given-names>LH</given-names></name><name><surname>May</surname><given-names>A</given-names></name></person-group><article-title>The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks</article-title><source>Brain.</source><year>2016</year><volume>139</volume><issue>Pt 7</issue><fpage>1987</fpage><lpage>1993</lpage><pub-id pub-id-type="doi">10.1093/brain/aww097</pub-id><?supplied-pmid 27190019?><pub-id pub-id-type="pmid">27190019</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maniyar</surname><given-names>FH</given-names></name><name><surname>Sprenger</surname><given-names>T</given-names></name><name><surname>Monteith</surname><given-names>T</given-names></name><name><surname>Schankin</surname><given-names>C</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks</article-title><source>Brain.</source><year>2014</year><volume>137</volume><issue>Pt 1</issue><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1093/brain/awt320</pub-id><?supplied-pmid 24277718?><pub-id pub-id-type="pmid">24277718</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Jakubowski</surname><given-names>M</given-names></name></person-group><article-title>Unitary hypothesis for multiple triggers of the pain and strain of migraine</article-title><source>J Comp Neurol</source><year>2005</year><volume>493</volume><issue>1</issue><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/cne.20688</pub-id><?supplied-pmid 16258903?><pub-id pub-id-type="pmid">16258903</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faithfull</surname><given-names>NS</given-names></name></person-group><article-title>Post-operative headache--a multifactorial analysis</article-title><source>Eur J Anaesthesiol</source><year>1991</year><volume>8</volume><issue>1</issue><fpage>59</fpage><lpage>63</lpage><?supplied-pmid 1874204?><pub-id pub-id-type="pmid">1874204</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alstadhaug</surname><given-names>KB</given-names></name></person-group><article-title>Migraine and the hypothalamus</article-title><source>Cephalalgia.</source><year>2009</year><volume>29</volume><issue>8</issue><fpage>809</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01814.x</pub-id><?supplied-pmid 19604254?><pub-id pub-id-type="pmid">19604254</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>KC</given-names></name><name><surname>Bates</surname><given-names>EA</given-names></name><name><surname>Shapiro</surname><given-names>RE</given-names></name><name><surname>Zyuzin</surname><given-names>J</given-names></name><name><surname>Hallows</surname><given-names>WC</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Casein kinase idelta mutations in familial migraine and advanced sleep phase</article-title><source>Sci Transl Med</source><year>2013</year><volume>5</volume><issue>183</issue><fpage>183ra56</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3005784</pub-id><?supplied-pmid 23636092?><pub-id pub-id-type="pmid">23636092</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahmen</surname><given-names>N</given-names></name><name><surname>Kasten</surname><given-names>M</given-names></name><name><surname>Wieczorek</surname><given-names>S</given-names></name><name><surname>Gencik</surname><given-names>M</given-names></name><name><surname>Epplen</surname><given-names>JT</given-names></name><name><surname>Ullrich</surname><given-names>B</given-names></name></person-group><article-title>Increased frequency of migraine in narcoleptic patients: a confirmatory study</article-title><source>Cephalalgia.</source><year>2003</year><volume>23</volume><issue>1</issue><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.2003.00343.x</pub-id><?supplied-pmid 12534574?><pub-id pub-id-type="pmid">12534574</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casez</surname><given-names>O</given-names></name><name><surname>Dananchet</surname><given-names>Y</given-names></name><name><surname>Besson</surname><given-names>G</given-names></name></person-group><article-title>Migraine and somnambulism</article-title><source>Neurology.</source><year>2005</year><volume>65</volume><issue>8</issue><fpage>1334</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000180937.20774.20</pub-id><?supplied-pmid 16247080?><pub-id pub-id-type="pmid">16247080</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>PR</given-names></name></person-group><article-title>Headache and sleep: shared pathophysiological mechanisms</article-title><source>Cephalalgia.</source><year>2014</year><volume>34</volume><issue>10</issue><fpage>725</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1177/0333102414541687</pub-id><?supplied-pmid 25053747?><pub-id pub-id-type="pmid">25053747</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjorklund</surname><given-names>A</given-names></name><name><surname>Skagerberg</surname><given-names>G</given-names></name></person-group><article-title>Evidence for a major spinal cord projection from the diencephalic A11 dopamine cell group in the rat using transmitter-specific fluorescent retrograde tracing</article-title><source>Brain Res</source><year>1979</year><volume>177</volume><issue>1</issue><fpage>170</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(79)90927-2</pub-id><?supplied-pmid 497819?><pub-id pub-id-type="pmid">497819</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charbit</surname><given-names>AR</given-names></name><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms</article-title><source>Pain.</source><year>2011</year><volume>152</volume><issue>10</issue><fpage>2365</fpage><lpage>2376</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2011.07.002</pub-id><?supplied-pmid 21868165?><pub-id pub-id-type="pmid">21868165</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charbit</surname><given-names>AR</given-names></name><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: an electrophysiological and immunohistochemical study</article-title><source>J Neurosci</source><year>2009</year><volume>29</volume><issue>40</issue><fpage>12532</fpage><lpage>12541</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2887-09.2009</pub-id><?supplied-pmid 19812328?><pub-id pub-id-type="pmid">19812328</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Chamberlain</surname><given-names>J</given-names></name></person-group><article-title>Nitric oxide alters the neuronal firing of the dopaminergic hypothalamic nucleus A11</article-title><source>Headache.</source><year>2014</year><volume>54</volume><fpage>6</fpage><lpage>7</lpage></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Chamberlain</surname><given-names>JH</given-names></name><name><surname>Torres-Perez</surname><given-names>JV</given-names></name><name><surname>Noormohamed</surname><given-names>F</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Bantel</surname><given-names>C</given-names></name><etal/></person-group><article-title>The A11 hypothalamic nucleus is susceptible to nitric oxide signalling</article-title><source>J Headache Pain</source><year>2014</year><volume>15</volume><fpage>F2</fpage><pub-id pub-id-type="doi">10.1186/1129-2377-15-S1-F2</pub-id><?supplied-pmid 4182264?><pub-id pub-id-type="pmid">4182264</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aurora</surname><given-names>SK</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Bowyer</surname><given-names>SM</given-names></name><name><surname>Welch</surname><given-names>KM</given-names></name></person-group><article-title>The occipital cortex is hyperexcitable in migraine: experimental evidence</article-title><source>Headache.</source><year>1999</year><volume>39</volume><issue>7</issue><fpage>469</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.1999.3907469.x</pub-id><?supplied-pmid 11279929?><pub-id pub-id-type="pmid">11279929</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulleners</surname><given-names>WM</given-names></name><name><surname>Chronicle</surname><given-names>EP</given-names></name><name><surname>Palmer</surname><given-names>JE</given-names></name><name><surname>Koehler</surname><given-names>PJ</given-names></name><name><surname>Vredeveld</surname><given-names>JW</given-names></name></person-group><article-title>Visual cortex excitability in migraine with and without aura</article-title><source>Headache.</source><year>2001</year><volume>41</volume><issue>6</issue><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2001.041006565.x</pub-id><?supplied-pmid 11437892?><pub-id pub-id-type="pmid">11437892</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denuelle</surname><given-names>M</given-names></name><name><surname>Boulloche</surname><given-names>N</given-names></name><name><surname>Payoux</surname><given-names>P</given-names></name><name><surname>Fabre</surname><given-names>N</given-names></name><name><surname>Trotter</surname><given-names>Y</given-names></name><name><surname>Geraud</surname><given-names>G</given-names></name></person-group><article-title>A PET study of photophobia during spontaneous migraine attacks</article-title><source>Neurology.</source><year>2011</year><volume>76</volume><issue>3</issue><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182074a57</pub-id><?supplied-pmid 21148120?><pub-id pub-id-type="pmid">21148120</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>KC</given-names></name></person-group><article-title>Turn down the lights!: an irritable occipital cortex in migraine without aura</article-title><source>Neurology.</source><year>2011</year><volume>76</volume><issue>3</issue><fpage>206</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182074bfb</pub-id><?supplied-pmid 21148117?><pub-id pub-id-type="pmid">21148117</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Pierelli</surname><given-names>F</given-names></name><name><surname>Schoenen</surname><given-names>J</given-names></name></person-group><article-title>Is the cerebral cortex hyperexcitable or hyperresponsive in migraine?</article-title><source>Cephalalgia.</source><year>2007</year><volume>27</volume><issue>12</issue><fpage>1427</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2007.01500.x</pub-id><?supplied-pmid 18034686?><pub-id pub-id-type="pmid">18034686</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Summ</surname><given-names>O</given-names></name><name><surname>Fredrick</surname><given-names>J</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine</article-title><source>Brain.</source><year>2016</year><volume>139</volume><issue>Pt 7</issue><fpage>2002</fpage><lpage>2014</lpage><pub-id pub-id-type="doi">10.1093/brain/aww118</pub-id><?supplied-pmid 27246325?><pub-id pub-id-type="pmid">27246325</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambru</surname><given-names>G</given-names></name><name><surname>Hill</surname><given-names>B</given-names></name><name><surname>Lloyd</surname><given-names>J</given-names></name><name><surname>Al-Kaisy</surname><given-names>A</given-names></name><name><surname>Andreou</surname><given-names>AP</given-names></name></person-group><article-title>Single-pulse transcranial magnetic stimulation (Stms) for the treatment of migraine: a prospective real world experience</article-title><source>Cephalalgia</source><year>2018</year><volume>38</volume><fpage>150</fpage></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Dodick</surname><given-names>DW</given-names></name><name><surname>Silberstein</surname><given-names>SD</given-names></name><name><surname>Saper</surname><given-names>JR</given-names></name><name><surname>Aurora</surname><given-names>SK</given-names></name><name><surname>Pearlman</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial</article-title><source>Lancet Neurol</source><year>2010</year><volume>9</volume><issue>4</issue><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(10)70054-5</pub-id><?supplied-pmid 20206581?><pub-id pub-id-type="pmid">20206581</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starling</surname><given-names>AJ</given-names></name><name><surname>Tepper</surname><given-names>SJ</given-names></name><name><surname>Marmura</surname><given-names>MJ</given-names></name><name><surname>Shamim</surname><given-names>EA</given-names></name><name><surname>Robbins</surname><given-names>MS</given-names></name><name><surname>Hindiyeh</surname><given-names>N</given-names></name><etal/></person-group><article-title>A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE study)</article-title><source>Cephalalgia.</source><year>2018</year><volume>38</volume><issue>6</issue><fpage>1038</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1177/0333102418762525</pub-id><?supplied-pmid 29504483?><pub-id pub-id-type="pmid">29504483</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>BK</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name></person-group><article-title>Migraine with aura and migraine without aura: an epidemiological study</article-title><source>Cephalalgia.</source><year>1992</year><volume>12</volume><issue>4</issue><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1992.1204221.x</pub-id><?supplied-pmid 1525797?><pub-id pub-id-type="pmid">1525797</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>J</given-names></name></person-group><article-title>Regional cerebral blood flow and oxygen metabolism during migraine with and without aura</article-title><source>Cephalalgia.</source><year>1998</year><volume>18</volume><issue>1</issue><fpage>2</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.1998.1801001-3.x</pub-id><?supplied-pmid 9601615?><pub-id pub-id-type="pmid">9601615</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arngrim</surname><given-names>N</given-names></name><name><surname>Hougaard</surname><given-names>A</given-names></name><name><surname>Ahmadi</surname><given-names>K</given-names></name><name><surname>Vestergaard</surname><given-names>MB</given-names></name><name><surname>Schytz</surname><given-names>HW</given-names></name><name><surname>Amin</surname><given-names>FM</given-names></name><etal/></person-group><article-title>Heterogenous migraine aura symptoms correlate with visual cortex functional magnetic resonance imaging responses</article-title><source>Ann Neurol</source><year>2017</year><volume>82</volume><issue>6</issue><fpage>925</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1002/ana.25096</pub-id><?supplied-pmid 29130510?><pub-id pub-id-type="pmid">29130510</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadjikhani</surname><given-names>N</given-names></name><name><surname>Sanchez Del Rio</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>O</given-names></name><name><surname>Schwartz</surname><given-names>D</given-names></name><name><surname>Bakker</surname><given-names>D</given-names></name><name><surname>Fischl</surname><given-names>B</given-names></name><etal/></person-group><article-title>Mechanisms of migraine aura revealed by functional MRI in human visual cortex</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><issue>8</issue><fpage>4687</fpage><lpage>4692</lpage><pub-id pub-id-type="doi">10.1073/pnas.071582498</pub-id><?supplied-pmid 11287655?><pub-id pub-id-type="pmid">11287655</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x000e3;o</surname><given-names>AA</given-names></name></person-group><article-title>Spreading depression of activity in cerebral cortex</article-title><source>J Neurophysiol</source><year>1944</year><volume>7</volume><fpage>359</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1152/jn.1944.7.6.359</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Summ</surname><given-names>O</given-names></name><name><surname>Charbit</surname><given-names>AR</given-names></name><name><surname>Romero-Reyes</surname><given-names>M</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Animal models of headache: from bedside to bench and back to bedside</article-title><source>Expert Rev Neurother</source><year>2010</year><volume>10</volume><issue>3</issue><fpage>389</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1586/ern.10.16</pub-id><?supplied-pmid 20187862?><pub-id pub-id-type="pmid">20187862</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Migraine, aura, and cortical spreading depression: why are we still talking about it?</article-title><source>Ann Neurol</source><year>2001</year><volume>49</volume><issue>1</issue><fpage>4</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1002/1531-8249(200101)49:1&#x0003c;4::AID-ANA3&#x0003e;3.0.CO;2-W</pub-id><?supplied-pmid 11198295?><pub-id pub-id-type="pmid">11198295</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moskowitz</surname><given-names>MA</given-names></name><name><surname>Nozaki</surname><given-names>K</given-names></name><name><surname>Kraig</surname><given-names>RP</given-names></name></person-group><article-title>Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms</article-title><source>J Neurosci</source><year>1993</year><volume>13</volume><issue>3</issue><fpage>1167</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.13-03-01167.1993</pub-id><?supplied-pmid 8382735?><pub-id pub-id-type="pmid">8382735</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolay</surname><given-names>H</given-names></name><name><surname>Reuter</surname><given-names>U</given-names></name><name><surname>Dunn</surname><given-names>AK</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Boas</surname><given-names>DA</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name></person-group><article-title>Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model</article-title><source>Nat Med</source><year>2002</year><volume>8</volume><issue>2</issue><fpage>136</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1038/nm0202-136</pub-id><?supplied-pmid 11821897?><pub-id pub-id-type="pmid">11821897</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Kainz</surname><given-names>V</given-names></name><name><surname>Noseda</surname><given-names>R</given-names></name><name><surname>Jakubowski</surname><given-names>M</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name></person-group><article-title>Activation of central trigeminovascular neurons by cortical spreading depression</article-title><source>Ann Neurol</source><year>2011</year><volume>69</volume><issue>5</issue><fpage>855</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1002/ana.22329</pub-id><?supplied-pmid 21416489?><pub-id pub-id-type="pmid">21416489</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Noseda</surname><given-names>R</given-names></name><name><surname>Kainz</surname><given-names>V</given-names></name><name><surname>Jakubowski</surname><given-names>M</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name></person-group><article-title>Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><issue>26</issue><fpage>8807</fpage><lpage>8814</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0511-10.2010</pub-id><?supplied-pmid 20592202?><pub-id pub-id-type="pmid">20592202</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iadecola</surname><given-names>C</given-names></name></person-group><article-title>From CSD to headache: a long and winding road</article-title><source>Nat Med</source><year>2002</year><volume>8</volume><issue>2</issue><fpage>110</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1038/nm0202-110</pub-id><?supplied-pmid 11821889?><pub-id pub-id-type="pmid">11821889</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebersberger</surname><given-names>A</given-names></name><name><surname>Schaible</surname><given-names>HG</given-names></name><name><surname>Averbeck</surname><given-names>B</given-names></name><name><surname>Richter</surname><given-names>F</given-names></name></person-group><article-title>Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache?</article-title><source>Ann Neurol</source><year>2001</year><volume>49</volume><issue>1</issue><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/1531-8249(200101)49:1&#x0003c;7::AID-ANA4&#x0003e;3.0.CO;2-K</pub-id><?supplied-pmid 11198299?><pub-id pub-id-type="pmid">11198299</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingvardsen</surname><given-names>BK</given-names></name><name><surname>Laursen</surname><given-names>H</given-names></name><name><surname>Olsen</surname><given-names>UB</given-names></name><name><surname>Hansen</surname><given-names>AJ</given-names></name></person-group><article-title>Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression</article-title><source>Pain.</source><year>1997</year><volume>72</volume><issue>3</issue><fpage>407</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(97)00069-9</pub-id><?supplied-pmid 9313281?><pub-id pub-id-type="pmid">9313281</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Sprenger</surname><given-names>T</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Cortical modulation of thalamic function during cortical spreading depression- unraveling a new central mechanism involved in migraine aura</article-title><source>J Headache Pain</source><year>2013</year><volume>14</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/1129-2377-14-S1-I6</pub-id><pub-id pub-id-type="pmid">23565801</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>BS</given-names></name><name><surname>Wolff</surname><given-names>HG</given-names></name></person-group><article-title>Experimental studies on headache. Pain sensitive structures of the head and their significance in headache</article-title><source>Arch Surg</source><year>1940</year><volume>41</volume><fpage>813</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1001/archsurg.1940.01210040002001</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shields</surname><given-names>KG</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?</article-title><source>Neurobiol Dis</source><year>2006</year><volume>23</volume><issue>3</issue><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2006.04.003</pub-id><?supplied-pmid 16875831?><pub-id pub-id-type="pmid">16875831</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway</article-title><source>Cephalalgia.</source><year>2011</year><volume>31</volume><issue>13</issue><fpage>1343</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.1177/0333102411418259</pub-id><?supplied-pmid 21893557?><pub-id pub-id-type="pmid">21893557</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Shields</surname><given-names>KG</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus</article-title><source>Neurobiol Dis</source><year>2010</year><volume>37</volume><issue>2</issue><fpage>314</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2009.10.007</pub-id><pub-id pub-id-type="pmid">19837163</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Therapeutic potential of novel glutamate receptor antagonists in migraine</article-title><source>Expert Opin Investig Drugs</source><year>2009</year><volume>18</volume><issue>6</issue><fpage>789</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1517/13543780902913792</pub-id><?supplied-pmid 19426123?><pub-id pub-id-type="pmid">19426123</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Ambrosini</surname><given-names>A</given-names></name><name><surname>Di Clemente</surname><given-names>L</given-names></name><name><surname>Magis</surname><given-names>D</given-names></name><name><surname>Fumal</surname><given-names>A</given-names></name><name><surname>Gerard</surname><given-names>P</given-names></name><etal/></person-group><article-title>Interictal abnormalities of gamma band activity in visual evoked responses in migraine: an indication of thalamocortical dysrhythmia?</article-title><source>Cephalalgia.</source><year>2007</year><volume>27</volume><issue>12</issue><fpage>1360</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2007.01466.x</pub-id><?supplied-pmid 17986271?><pub-id pub-id-type="pmid">17986271</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>FM</given-names></name><name><surname>Hougaard</surname><given-names>A</given-names></name><name><surname>Magon</surname><given-names>S</given-names></name><name><surname>Sprenger</surname><given-names>T</given-names></name><name><surname>Wolfram</surname><given-names>F</given-names></name><name><surname>Rostrup</surname><given-names>E</given-names></name><etal/></person-group><article-title>Altered thalamic connectivity during spontaneous attacks of migraine without aura: a resting-state fMRI study</article-title><source>Cephalalgia.</source><year>2018</year><volume>38</volume><issue>7</issue><fpage>1237</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1177/0333102417729113</pub-id><?supplied-pmid 28853611?><pub-id pub-id-type="pmid">28853611</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Zeng</surname><given-names>F</given-names></name><name><surname>Maleki</surname><given-names>N</given-names></name><name><surname>Lan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Abnormal thalamocortical network dynamics in migraine</article-title><source>Neurology.</source><year>2019</year><volume>92</volume><issue>23</issue><fpage>e2706</fpage><lpage>e2e16</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000007607</pub-id><?supplied-pmid 31076535?><pub-id pub-id-type="pmid">31076535</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noseda</surname><given-names>R</given-names></name><name><surname>Kainz</surname><given-names>V</given-names></name><name><surname>Jakubowski</surname><given-names>M</given-names></name><name><surname>Gooley</surname><given-names>JJ</given-names></name><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Digre</surname><given-names>K</given-names></name><etal/></person-group><article-title>A neural mechanism for exacerbation of headache by light</article-title><source>Nat Neurosci</source><year>2010</year><volume>13</volume><issue>2</issue><fpage>239</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1038/nn.2475</pub-id><?supplied-pmid 20062053?><pub-id pub-id-type="pmid">20062053</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filippov</surname><given-names>IV</given-names></name><name><surname>Williams</surname><given-names>WC</given-names></name><name><surname>Krebs</surname><given-names>AA</given-names></name><name><surname>Pugachev</surname><given-names>KS</given-names></name></person-group><article-title>Dynamics of infraslow potentials in the primary auditory cortex: component analysis and contribution of specific thalamic-cortical and non-specific brainstem-cortical influences</article-title><source>Brain Res</source><year>2008</year><volume>1219</volume><fpage>66</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2008.04.011</pub-id><?supplied-pmid 18534565?><pub-id pub-id-type="pmid">18534565</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Jakubowski</surname><given-names>M</given-names></name><name><surname>Garcia-Nicas</surname><given-names>E</given-names></name><name><surname>Kainz</surname><given-names>V</given-names></name><name><surname>Bajwa</surname><given-names>Z</given-names></name><name><surname>Hargreaves</surname><given-names>R</given-names></name><etal/></person-group><article-title>Thalamic sensitization transforms localized pain into widespread allodynia</article-title><source>Ann Neurol</source><year>2010</year><volume>68</volume><issue>1</issue><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1002/ana.21994</pub-id><?supplied-pmid 20582997?><pub-id pub-id-type="pmid">20582997</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Diencephalic and brainstem mechanisms in migraine</article-title><source>Nat Rev Neurosci</source><year>2011</year><volume>12</volume><issue>10</issue><fpage>570</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1038/nrn3057</pub-id><?supplied-pmid 21931334?><pub-id pub-id-type="pmid">21931334</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiller</surname><given-names>C</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Limmroth</surname><given-names>V</given-names></name><name><surname>Juptner</surname><given-names>M</given-names></name><name><surname>Kaube</surname><given-names>H</given-names></name><name><surname>Schayck</surname><given-names>RV</given-names></name><etal/></person-group><article-title>Brain stem activation in spontaneous human migraine attacks</article-title><source>Nat Med</source><year>1995</year><volume>1</volume><issue>7</issue><fpage>658</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1038/nm0795-658</pub-id><?supplied-pmid 7585147?><pub-id pub-id-type="pmid">7585147</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afridi</surname><given-names>SK</given-names></name><name><surname>Giffin</surname><given-names>NJ</given-names></name><name><surname>Kaube</surname><given-names>H</given-names></name><name><surname>Friston</surname><given-names>KJ</given-names></name><name><surname>Ward</surname><given-names>NS</given-names></name><name><surname>Frackowiak</surname><given-names>RS</given-names></name><etal/></person-group><article-title>A positron emission tomographic study in spontaneous migraine</article-title><source>Arch Neurol</source><year>2005</year><volume>62</volume><issue>8</issue><fpage>1270</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.1001/archneur.62.8.1270</pub-id><?supplied-pmid 16087768?><pub-id pub-id-type="pmid">16087768</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matharu</surname><given-names>MS</given-names></name><name><surname>Bartsch</surname><given-names>T</given-names></name><name><surname>Ward</surname><given-names>N</given-names></name><name><surname>Frackowiak</surname><given-names>RS</given-names></name><name><surname>Weiner</surname><given-names>R</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study</article-title><source>Brain.</source><year>2004</year><volume>127</volume><issue>Pt 1</issue><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1093/brain/awh022</pub-id><?supplied-pmid 14607792?><pub-id pub-id-type="pmid">14607792</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afridi</surname><given-names>SK</given-names></name><name><surname>Matharu</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Kaube</surname><given-names>H</given-names></name><name><surname>Friston</surname><given-names>KJ</given-names></name><name><surname>Frackowiak</surname><given-names>RS</given-names></name><etal/></person-group><article-title>A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate</article-title><source>Brain.</source><year>2005</year><volume>128</volume><issue>Pt 4</issue><fpage>932</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1093/brain/awh416</pub-id><?supplied-pmid 15705611?><pub-id pub-id-type="pmid">15705611</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Bhatia</surname><given-names>MS</given-names></name></person-group><article-title>A report of cranial autonomic symptoms in migraineurs</article-title><source>Cephalalgia.</source><year>2007</year><volume>27</volume><issue>1</issue><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2006.01237.x</pub-id><?supplied-pmid 17212679?><pub-id pub-id-type="pmid">17212679</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Elsas</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>TJ</given-names></name></person-group><article-title>Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat</article-title><source>Microsc Res Tech</source><year>2001</year><volume>53</volume><issue>3</issue><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1002/jemt.1086</pub-id><?supplied-pmid 11301497?><pub-id pub-id-type="pmid">11301497</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarnitsky</surname><given-names>D</given-names></name><name><surname>Goor-Aryeh</surname><given-names>I</given-names></name><name><surname>Bajwa</surname><given-names>ZH</given-names></name><name><surname>Ransil</surname><given-names>BI</given-names></name><name><surname>Cutrer</surname><given-names>FM</given-names></name><name><surname>Sottile</surname><given-names>A</given-names></name><etal/></person-group><article-title>2003 Wolff award: possible parasympathetic contributions to peripheral and central sensitization during migraine</article-title><source>Headache.</source><year>2003</year><volume>43</volume><issue>7</issue><fpage>704</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2003.03127.x</pub-id><?supplied-pmid 12890124?><pub-id pub-id-type="pmid">12890124</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>MG</given-names></name><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>McMahon</surname><given-names>SB</given-names></name><name><surname>Spanswick</surname><given-names>D</given-names></name></person-group><article-title>Pharmacology of reflex blinks in the rat: a novel model for headache research</article-title><source>J Headache Pain</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>96</fpage><pub-id pub-id-type="doi">10.1186/s10194-016-0686-x</pub-id><?supplied-pmid 27770405?><pub-id pub-id-type="pmid">27770405</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Ashina</surname><given-names>M</given-names></name><name><surname>Tfelt-Hansen</surname><given-names>P</given-names></name></person-group><article-title>Origin of pain in migraine: evidence for peripheral sensitisation</article-title><source>Lancet Neurol</source><year>2009</year><volume>8</volume><issue>7</issue><fpage>679</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(09)70090-0</pub-id><?supplied-pmid 19539239?><pub-id pub-id-type="pmid">19539239</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wolff</surname><given-names>HG</given-names></name></person-group><source>Headache and other head pain</source><year>1948</year><edition>1</edition><publisher-loc>New York</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penfield</surname><given-names>W</given-names></name><name><surname>McNaughton</surname><given-names>F</given-names></name></person-group><article-title>Dural headache and innervation of the dura matter</article-title><source>Arch Neurol Psychiatr</source><year>1940</year><volume>44</volume><fpage>43</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1001/archneurpsyc.1940.02280070051003</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Ekman</surname><given-names>R</given-names></name></person-group><article-title>Vasoactive peptide release in the extracerebral circulation of humans during migraine headache</article-title><source>Ann Neurol</source><year>1990</year><volume>28</volume><issue>2</issue><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1002/ana.410280213</pub-id><?supplied-pmid 1699472?><pub-id pub-id-type="pmid">1699472</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Ekman</surname><given-names>R</given-names></name></person-group><article-title>Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system</article-title><source>Ann Neurol</source><year>1988</year><volume>23</volume><issue>2</issue><fpage>193</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1002/ana.410230214</pub-id><?supplied-pmid 2454066?><pub-id pub-id-type="pmid">2454066</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>GA</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Zagami</surname><given-names>AS</given-names></name><name><surname>Duckworth</surname><given-names>JW</given-names></name></person-group><article-title>Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat</article-title><source>Brain Res</source><year>1988</year><volume>453</volume><issue>1&#x02013;2</issue><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(88)90152-7</pub-id><?supplied-pmid 3261196?><pub-id pub-id-type="pmid">3261196</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storer</surname><given-names>RJ</given-names></name><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat</article-title><source>Br J Pharmacol</source><year>2004</year><volume>142</volume><issue>7</issue><fpage>1171</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0705807</pub-id><?supplied-pmid 15237097?><pub-id pub-id-type="pmid">15237097</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biella</surname><given-names>G</given-names></name><name><surname>Panara</surname><given-names>C</given-names></name><name><surname>Pecile</surname><given-names>A</given-names></name><name><surname>Sotgiu</surname><given-names>ML</given-names></name></person-group><article-title>Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo</article-title><source>Brain Res</source><year>1991</year><volume>559</volume><issue>2</issue><fpage>352</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(91)90024-P</pub-id><?supplied-pmid 1724408?><pub-id pub-id-type="pmid">1724408</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leem</surname><given-names>JW</given-names></name><name><surname>Gwak</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>EH</given-names></name><name><surname>Chung</surname><given-names>SS</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Nam</surname><given-names>TS</given-names></name></person-group><article-title>Effects of iontophoretically applied substance P, calcitonin gene-related peptide on excitability of dorsal horn neurones in rats</article-title><source>Yonsei Med J</source><year>2001</year><volume>42</volume><issue>1</issue><fpage>74</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.3349/ymj.2001.42.1.74</pub-id><?supplied-pmid 11293504?><pub-id pub-id-type="pmid">11293504</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schankin</surname><given-names>CJ</given-names></name><name><surname>Maniyar</surname><given-names>FH</given-names></name><name><surname>Seo</surname><given-names>Y</given-names></name><name><surname>Kori</surname><given-names>S</given-names></name><name><surname>Eller</surname><given-names>M</given-names></name><name><surname>Chou</surname><given-names>DE</given-names></name><etal/></person-group><article-title>Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine</article-title><source>Brain.</source><year>2016</year><volume>139</volume><issue>Pt 7</issue><fpage>1994</fpage><lpage>2001</lpage><pub-id pub-id-type="doi">10.1093/brain/aww096</pub-id><?supplied-pmid 27234268?><pub-id pub-id-type="pmid">27234268</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hougaard</surname><given-names>A</given-names></name><name><surname>Amin</surname><given-names>FM</given-names></name><name><surname>Christensen</surname><given-names>CE</given-names></name><name><surname>Younis</surname><given-names>S</given-names></name><name><surname>Wolfram</surname><given-names>F</given-names></name><name><surname>Cramer</surname><given-names>SP</given-names></name><etal/></person-group><article-title>Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura</article-title><source>Brain.</source><year>2017</year><volume>140</volume><issue>6</issue><fpage>1633</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1093/brain/awx089</pub-id><?supplied-pmid 28430860?><pub-id pub-id-type="pmid">28430860</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Nilsson</surname><given-names>E</given-names></name><name><surname>Jansen-Olesen</surname><given-names>I</given-names></name></person-group><article-title>Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery</article-title><source>Br J Pharmacol</source><year>2007</year><volume>150</volume><issue>5</issue><fpage>633</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0707134</pub-id><?supplied-pmid 17245362?><pub-id pub-id-type="pmid">17245362</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassen</surname><given-names>LH</given-names></name><name><surname>Haderslev</surname><given-names>PA</given-names></name><name><surname>Jacobsen</surname><given-names>VB</given-names></name><name><surname>Iversen</surname><given-names>HK</given-names></name><name><surname>Sperling</surname><given-names>B</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name></person-group><article-title>CGRP may play a causative role in migraine</article-title><source>Cephalalgia.</source><year>2002</year><volume>22</volume><issue>1</issue><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1046/j.1468-2982.2002.00310.x</pub-id><?supplied-pmid 11993614?><pub-id pub-id-type="pmid">11993614</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassen</surname><given-names>LH</given-names></name><name><surname>Thomsen</surname><given-names>LL</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name></person-group><article-title>Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine</article-title><source>Neuroreport.</source><year>1995</year><volume>6</volume><issue>11</issue><fpage>1475</fpage><lpage>1479</lpage><pub-id pub-id-type="doi">10.1097/00001756-199507310-00003</pub-id><?supplied-pmid 7579128?><pub-id pub-id-type="pmid">7579128</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoonman</surname><given-names>GG</given-names></name><name><surname>van der Grond</surname><given-names>J</given-names></name><name><surname>Kortmann</surname><given-names>C</given-names></name><name><surname>van der Geest</surname><given-names>RJ</given-names></name><name><surname>Terwindt</surname><given-names>GM</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name></person-group><article-title>Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study</article-title><source>Brain.</source><year>2008</year><volume>131</volume><issue>Pt 8</issue><fpage>2192</fpage><lpage>2200</lpage><pub-id pub-id-type="doi">10.1093/brain/awn094</pub-id><?supplied-pmid 18502781?><pub-id pub-id-type="pmid">18502781</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Trimboli</surname><given-names>M</given-names></name><name><surname>Al-Kaisy</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Palmisani</surname><given-names>S</given-names></name><name><surname>Fenech</surname><given-names>C</given-names></name><etal/></person-group><article-title>Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for health and care excellence UK technology appraisal</article-title><source>Eur J Neurol</source><year>2018</year><volume>25</volume><issue>8</issue><fpage>1069</fpage><lpage>1e83</lpage><pub-id pub-id-type="doi">10.1111/ene.13657</pub-id><?supplied-pmid 29617060?><pub-id pub-id-type="pmid">29617060</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>The</surname><given-names>LN</given-names></name></person-group><article-title>Complicated decisions on new migraine-prevention therapies</article-title><source>Lancet Neurol</source><year>2019</year><volume>18</volume><issue>3</issue><fpage>221</fpage><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30041-9</pub-id><pub-id pub-id-type="pmid">30784544</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodick</surname><given-names>DW</given-names></name></person-group><article-title>CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications</article-title><source>Cephalalgia.</source><year>2019</year><volume>39</volume><issue>3</issue><fpage>445</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1177/0333102418821662</pub-id><?supplied-pmid 30661365?><pub-id pub-id-type="pmid">30661365</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundblad</surname><given-names>C</given-names></name><name><surname>Haanes</surname><given-names>KA</given-names></name><name><surname>Grande</surname><given-names>G</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name></person-group><article-title>Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage</article-title><source>J Headache Pain</source><year>2015</year><volume>16</volume><fpage>91</fpage><pub-id pub-id-type="doi">10.1186/s10194-015-0575-8</pub-id><?supplied-pmid 26512021?><pub-id pub-id-type="pmid">26512021</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation</article-title><source>Br J Pharmacol</source><year>2009</year><volume>157</volume><issue>3</issue><fpage>464</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00142.x</pub-id><?supplied-pmid 19309356?><pub-id pub-id-type="pmid">19309356</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreou</surname><given-names>AP</given-names></name><name><surname>Holland</surname><given-names>PR</given-names></name><name><surname>Lasalandra</surname><given-names>M</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors</article-title><source>Pain</source><year>2015</year><volume>156</volume><issue>3</issue><fpage>439</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1097/01.j.pain.0000460325.25762.c0</pub-id><?supplied-pmid 25679470?><pub-id pub-id-type="pmid">25679470</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>FT</given-names><suffix>3rd</suffix></name><name><surname>Mawad</surname><given-names>M</given-names></name><name><surname>Mohr</surname><given-names>JP</given-names></name><name><surname>Stein</surname><given-names>B</given-names></name><name><surname>Hilal</surname><given-names>S</given-names></name><name><surname>Michelsen</surname><given-names>WJ</given-names></name></person-group><article-title>Focal headache during balloon inflation in the internal carotid and middle cerebral arteries</article-title><source>Stroke.</source><year>1990</year><volume>21</volume><issue>4</issue><fpage>555</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1161/01.STR.21.4.555</pub-id><?supplied-pmid 2326836?><pub-id pub-id-type="pmid">2326836</pub-id></element-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>E</given-names></name><name><surname>Moriguchi</surname><given-names>H</given-names></name><name><surname>Takizawa</surname><given-names>S</given-names></name><name><surname>Horie</surname><given-names>T</given-names></name><name><surname>Yanagimachi</surname><given-names>N</given-names></name><name><surname>Takagi</surname><given-names>S</given-names></name></person-group><article-title>The middle meningial artery during a migraine attack: 3T magnetic resonance angiography study</article-title><source>Intern Med</source><year>2009</year><volume>48</volume><issue>24</issue><fpage>2133</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.48.2565</pub-id><?supplied-pmid 20009407?><pub-id pub-id-type="pmid">20009407</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Amin</surname><given-names>FM</given-names></name><name><surname>Christensen</surname><given-names>CE</given-names></name><name><surname>Ghanizada</surname><given-names>H</given-names></name><name><surname>Younis</surname><given-names>S</given-names></name><name><surname>Olinger</surname><given-names>ACR</given-names></name><etal/></person-group><article-title>Meningeal contribution to migraine pain: a magnetic resonance angiography study</article-title><source>Brain.</source><year>2019</year><volume>142</volume><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1093/brain/awy300</pub-id><?supplied-pmid 30590467?><pub-id pub-id-type="pmid">30590467</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friberg</surname><given-names>L</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Iversen</surname><given-names>HK</given-names></name><name><surname>Sperling</surname><given-names>B</given-names></name></person-group><article-title>Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan</article-title><source>Lancet.</source><year>1991</year><volume>338</volume><issue>8758</issue><fpage>13</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(91)90005-A</pub-id><?supplied-pmid 1676084?><pub-id pub-id-type="pmid">1676084</pub-id></element-citation></ref><ref id="CR161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iversen</surname><given-names>HK</given-names></name><name><surname>Nielsen</surname><given-names>TH</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Tfelt-Hansen</surname><given-names>P</given-names></name></person-group><article-title>Arterial responses during migraine headache</article-title><source>Lancet.</source><year>1990</year><volume>336</volume><issue>8719</issue><fpage>837</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(90)92339-J</pub-id><?supplied-pmid 1976878?><pub-id pub-id-type="pmid">1976878</pub-id></element-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashina</surname><given-names>M</given-names></name></person-group><article-title>Vascular changes have a primary role in migraine</article-title><source>Cephalalgia.</source><year>2012</year><volume>32</volume><issue>5</issue><fpage>428</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1177/0333102412438978</pub-id><?supplied-pmid 22523234?><pub-id pub-id-type="pmid">22523234</pub-id></element-citation></ref><ref id="CR163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruuse</surname><given-names>C</given-names></name><name><surname>Thomsen</surname><given-names>LL</given-names></name><name><surname>Birk</surname><given-names>S</given-names></name><name><surname>Olesen</surname><given-names>J</given-names></name></person-group><article-title>Migraine can be induced by sildenafil without changes in middle cerebral artery diameter</article-title><source>Brain.</source><year>2003</year><volume>126</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1093/brain/awg009</pub-id><?supplied-pmid 12477710?><pub-id pub-id-type="pmid">12477710</pub-id></element-citation></ref><ref id="CR164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>B</given-names></name><name><surname>Dussor</surname><given-names>G</given-names></name></person-group><article-title>Neurovascular contributions to migraine: moving beyond vasodilation</article-title><source>Neuroscience.</source><year>2016</year><volume>338</volume><fpage>130</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.06.012</pub-id><?supplied-pmid 27312704?><pub-id pub-id-type="pmid">27312704</pub-id></element-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname><given-names>P</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>The migraine postdrome</article-title><source>Curr Opin Neurol</source><year>2016</year><volume>29</volume><issue>3</issue><fpage>299</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1097/WCO.0000000000000310</pub-id><?supplied-pmid 26886356?><pub-id pub-id-type="pmid">26886356</pub-id></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buse</surname><given-names>DC</given-names></name><name><surname>Manack</surname><given-names>AN</given-names></name><name><surname>Fanning</surname><given-names>KM</given-names></name><name><surname>Serrano</surname><given-names>D</given-names></name><name><surname>Reed</surname><given-names>ML</given-names></name><name><surname>Turkel</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study</article-title><source>Headache.</source><year>2012</year><volume>52</volume><issue>10</issue><fpage>1456</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2012.02223.x</pub-id><?supplied-pmid 22830411?><pub-id pub-id-type="pmid">22830411</pub-id></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natoli</surname><given-names>JL</given-names></name><name><surname>Manack</surname><given-names>A</given-names></name><name><surname>Dean</surname><given-names>B</given-names></name><name><surname>Butler</surname><given-names>Q</given-names></name><name><surname>Turkel</surname><given-names>CC</given-names></name><name><surname>Stovner</surname><given-names>L</given-names></name><etal/></person-group><article-title>Global prevalence of chronic migraine: a systematic review</article-title><source>Cephalalgia.</source><year>2010</year><volume>30</volume><issue>5</issue><fpage>599</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2982.2009.01941.x</pub-id><?supplied-pmid 19614702?><pub-id pub-id-type="pmid">19614702</pub-id></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moschiano</surname><given-names>F</given-names></name><name><surname>D'Amico</surname><given-names>D</given-names></name><name><surname>Schieroni</surname><given-names>F</given-names></name><name><surname>Bussone</surname><given-names>G</given-names></name></person-group><article-title>Neurobiology of chronic migraine</article-title><source>Neurol Sci</source><year>2003</year><volume>24</volume><issue>Suppl 2</issue><fpage>S94</fpage><lpage>S96</lpage><pub-id pub-id-type="doi">10.1007/s100720300051</pub-id><?supplied-pmid 12811602?><pub-id pub-id-type="pmid">12811602</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name></person-group><article-title>Is migraine a progressive brain disease?</article-title><source>JAMA.</source><year>2004</year><volume>291</volume><issue>4</issue><fpage>493</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1001/jama.291.4.493</pub-id><?supplied-pmid 14747508?><pub-id pub-id-type="pmid">14747508</pub-id></element-citation></ref><ref id="CR170"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manack</surname><given-names>AN</given-names></name><name><surname>Buse</surname><given-names>DC</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Chronic migraine: epidemiology and disease burden</article-title><source>Curr Pain Headache Rep</source><year>2011</year><volume>15</volume><issue>1</issue><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1007/s11916-010-0157-z</pub-id><?supplied-pmid 21063918?><pub-id pub-id-type="pmid">21063918</pub-id></element-citation></ref><ref id="CR171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>NT</given-names></name><name><surname>Reuveni</surname><given-names>U</given-names></name><name><surname>Perez</surname><given-names>F</given-names></name></person-group><article-title>Transformed or evolutive migraine</article-title><source>Headache.</source><year>1987</year><volume>27</volume><issue>2</issue><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.1987.hed2702102.x</pub-id><?supplied-pmid 3570762?><pub-id pub-id-type="pmid">3570762</pub-id></element-citation></ref><ref id="CR172"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>A</given-names></name><name><surname>Schulte</surname><given-names>LH</given-names></name></person-group><article-title>Chronic migraine: risk factors, mechanisms and treatment</article-title><source>Nat Rev Neurol</source><year>2016</year><volume>12</volume><issue>8</issue><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2016.93</pub-id><?supplied-pmid 27389092?><pub-id pub-id-type="pmid">27389092</pub-id></element-citation></ref><ref id="CR173"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scher</surname><given-names>AI</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Ricci</surname><given-names>JA</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Factors associated with the onset and remission of chronic daily headache in a population-based study</article-title><source>Pain.</source><year>2003</year><volume>106</volume><issue>1&#x02013;2</issue><fpage>81</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00293-8</pub-id><?supplied-pmid 14581114?><pub-id pub-id-type="pmid">14581114</pub-id></element-citation></ref><ref id="CR174"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>NT</given-names></name><name><surname>Kurman</surname><given-names>R</given-names></name><name><surname>Perez</surname><given-names>F</given-names></name></person-group><article-title>Drug induced refractory headache--clinical features and management</article-title><source>Headache.</source><year>1990</year><volume>30</volume><issue>10</issue><fpage>634</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.1990.hed3010634.x</pub-id><?supplied-pmid 2272811?><pub-id pub-id-type="pmid">2272811</pub-id></element-citation></ref><ref id="CR175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsarava</surname><given-names>Z</given-names></name><name><surname>Schneeweiss</surname><given-names>S</given-names></name><name><surname>Kurth</surname><given-names>T</given-names></name><name><surname>Kroener</surname><given-names>U</given-names></name><name><surname>Fritsche</surname><given-names>G</given-names></name><name><surname>Eikermann</surname><given-names>A</given-names></name><etal/></person-group><article-title>Incidence and predictors for chronicity of headache in patients with episodic migraine</article-title><source>Neurology.</source><year>2004</year><volume>62</volume><issue>5</issue><fpage>788</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1212/01.WNL.0000113747.18760.D2</pub-id><?supplied-pmid 15007133?><pub-id pub-id-type="pmid">15007133</pub-id></element-citation></ref><ref id="CR176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Fanning</surname><given-names>KM</given-names></name><name><surname>Serrano</surname><given-names>D</given-names></name><name><surname>Reed</surname><given-names>ML</given-names></name><name><surname>Cady</surname><given-names>R</given-names></name><name><surname>Buse</surname><given-names>DC</given-names></name></person-group><article-title>Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine</article-title><source>Neurology.</source><year>2015</year><volume>84</volume><issue>7</issue><fpage>688</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000001256</pub-id><?supplied-pmid 25609757?><pub-id pub-id-type="pmid">25609757</pub-id></element-citation></ref><ref id="CR177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashina</surname><given-names>S</given-names></name><name><surname>Serrano</surname><given-names>D</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Maizels</surname><given-names>M</given-names></name><name><surname>Manack</surname><given-names>AN</given-names></name><name><surname>Turkel</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Depression and risk of transformation of episodic to chronic migraine</article-title><source>J Headache Pain</source><year>2012</year><volume>13</volume><issue>8</issue><fpage>615</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1007/s10194-012-0479-9</pub-id><?supplied-pmid 23007859?><pub-id pub-id-type="pmid">23007859</pub-id></element-citation></ref><ref id="CR178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Obesity is a risk factor for transformed migraine but not chronic tension-type headache</article-title><source>Neurology.</source><year>2006</year><volume>67</volume><issue>2</issue><fpage>252</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000225052.35019.f9</pub-id><?supplied-pmid 16864817?><pub-id pub-id-type="pmid">16864817</pub-id></element-citation></ref><ref id="CR179"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Di Renzo</surname><given-names>A</given-names></name><name><surname>Petolicchio</surname><given-names>B</given-names></name><name><surname>Tinelli</surname><given-names>E</given-names></name><name><surname>Di Lorenzo</surname><given-names>C</given-names></name><name><surname>Parisi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Aberrant interactions of cortical networks in chronic migraine: a resting-state fMRI study</article-title><source>Neurology.</source><year>2019</year><volume>92</volume><issue>22</issue><fpage>e2550</fpage><lpage>e25e8</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000007577</pub-id><?supplied-pmid 31053665?><pub-id pub-id-type="pmid">31053665</pub-id></element-citation></ref><ref id="CR180"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aradi</surname><given-names>M</given-names></name><name><surname>Schwarcz</surname><given-names>A</given-names></name><name><surname>Perlaki</surname><given-names>G</given-names></name><name><surname>Orsi</surname><given-names>G</given-names></name><name><surname>Kovacs</surname><given-names>N</given-names></name><name><surname>Trauninger</surname><given-names>A</given-names></name><etal/></person-group><article-title>Quantitative MRI studies of chronic brain white matter hyperintensities in migraine patients</article-title><source>Headache.</source><year>2013</year><volume>53</volume><issue>5</issue><fpage>752</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1111/head.12013</pub-id><?supplied-pmid 23278630?><pub-id pub-id-type="pmid">23278630</pub-id></element-citation></ref><ref id="CR181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiapparini</surname><given-names>L</given-names></name><name><surname>Ferraro</surname><given-names>S</given-names></name><name><surname>Grazzi</surname><given-names>L</given-names></name><name><surname>Bussone</surname><given-names>G</given-names></name></person-group><article-title>Neuroimaging in chronic migraine</article-title><source>Neurol Sci</source><year>2010</year><volume>31</volume><issue>Suppl 1</issue><fpage>S19</fpage><lpage>S22</lpage><pub-id pub-id-type="doi">10.1007/s10072-010-0266-9</pub-id><?supplied-pmid 20464577?><pub-id pub-id-type="pmid">20464577</pub-id></element-citation></ref><ref id="CR182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocca</surname><given-names>MA</given-names></name><name><surname>Ceccarelli</surname><given-names>A</given-names></name><name><surname>Falini</surname><given-names>A</given-names></name><name><surname>Tortorella</surname><given-names>P</given-names></name><name><surname>Colombo</surname><given-names>B</given-names></name><name><surname>Pagani</surname><given-names>E</given-names></name><etal/></person-group><article-title>Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral grey matter abnormalities in patients with migraine</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2006</year><volume>77</volume><issue>5</issue><fpage>686</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1136/jnnp.2005.080002</pub-id><?supplied-pmid 16614037?><pub-id pub-id-type="pmid">16614037</pub-id></element-citation></ref><ref id="CR183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valfre</surname><given-names>W</given-names></name><name><surname>Rainero</surname><given-names>I</given-names></name><name><surname>Bergui</surname><given-names>M</given-names></name><name><surname>Pinessi</surname><given-names>L</given-names></name></person-group><article-title>Voxel-based morphometry reveals gray matter abnormalities in migraine</article-title><source>Headache.</source><year>2008</year><volume>48</volume><issue>1</issue><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2007.00723.x</pub-id><?supplied-pmid 18184293?><pub-id pub-id-type="pmid">18184293</pub-id></element-citation></ref><ref id="CR184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>M</given-names></name><name><surname>Di</surname><given-names>W</given-names></name><name><surname>Qi</surname><given-names>W</given-names></name><etal/></person-group><article-title>White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study</article-title><source>J Neurol</source><year>2014</year><volume>261</volume><issue>4</issue><fpage>784</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1007/s00415-014-7267-1</pub-id><?supplied-pmid 24535135?><pub-id pub-id-type="pmid">24535135</pub-id></element-citation></ref><ref id="CR185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Schoenen</surname><given-names>J</given-names></name></person-group><article-title>Cortical excitability in chronic migraine</article-title><source>Curr Pain Headache Rep</source><year>2012</year><volume>16</volume><issue>1</issue><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1007/s11916-011-0231-1</pub-id><?supplied-pmid 22076672?><pub-id pub-id-type="pmid">22076672</pub-id></element-citation></ref><ref id="CR186"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosentino</surname><given-names>G</given-names></name><name><surname>Fierro</surname><given-names>B</given-names></name><name><surname>Vigneri</surname><given-names>S</given-names></name><name><surname>Talamanca</surname><given-names>S</given-names></name><name><surname>Paladino</surname><given-names>P</given-names></name><name><surname>Baschi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cyclical changes of cortical excitability and metaplasticity in migraine: evidence from a repetitive transcranial magnetic stimulation study</article-title><source>Pain.</source><year>2014</year><volume>155</volume><issue>6</issue><fpage>1070</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2014.02.024</pub-id><?supplied-pmid 24631596?><pub-id pub-id-type="pmid">24631596</pub-id></element-citation></ref><ref id="CR187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Haanes</surname><given-names>KA</given-names></name><name><surname>Warfvinge</surname><given-names>K</given-names></name></person-group><article-title>Does inflammation have a role in migraine?</article-title><source>Nat Rev Neurol</source><year>2019</year><volume>15</volume><issue>8</issue><fpage>483</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1038/s41582-019-0216-y</pub-id><?supplied-pmid 31263254?><pub-id pub-id-type="pmid">31263254</pub-id></element-citation></ref><ref id="CR188"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moskowitz</surname><given-names>MA</given-names></name></person-group><article-title>Neurogenic inflammation in the pathophysiology and treatment of migraine</article-title><source>Neurology.</source><year>1993</year><volume>43</volume><issue>6 Suppl 3</issue><fpage>S16</fpage><lpage>S20</lpage><?supplied-pmid 8389008?><pub-id pub-id-type="pmid">8389008</pub-id></element-citation></ref><ref id="CR189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Network meta-analysis of migraine disorder treatment by NSAIDs and triptans</article-title><source>J Headache Pain</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>113</fpage><pub-id pub-id-type="doi">10.1186/s10194-016-0703-0</pub-id><?supplied-pmid 27957624?><pub-id pub-id-type="pmid">27957624</pub-id></element-citation></ref><ref id="CR190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>SM</given-names></name><name><surname>Mookadam</surname><given-names>F</given-names></name><name><surname>Cha</surname><given-names>SS</given-names></name><name><surname>Freeman</surname><given-names>JA</given-names></name><name><surname>Starling</surname><given-names>AJ</given-names></name><name><surname>Mookadam</surname><given-names>M</given-names></name></person-group><article-title>Greater occipital nerve block for acute treatment of migraine headache: a large retrospective cohort study</article-title><source>J Am Board Fam Med</source><year>2018</year><volume>31</volume><issue>2</issue><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.3122/jabfm.2018.02.170188</pub-id><?supplied-pmid 29535237?><pub-id pub-id-type="pmid">29535237</pub-id></element-citation></ref><ref id="CR191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashipazha</surname><given-names>D</given-names></name><name><surname>Nakhostin-Mortazavi</surname><given-names>A</given-names></name><name><surname>Mohammadianinejad</surname><given-names>SE</given-names></name><name><surname>Bahadoram</surname><given-names>M</given-names></name><name><surname>Zandifar</surname><given-names>S</given-names></name><name><surname>Tarahomi</surname><given-names>S</given-names></name></person-group><article-title>Preventive effect of greater occipital nerve block on severity and frequency of migraine headache</article-title><source>Global J Health Sci</source><year>2014</year><volume>6</volume><issue>6</issue><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.5539/gjhs.v6n6p209</pub-id></element-citation></ref><ref id="CR192"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura-Craig</surname><given-names>M</given-names></name><name><surname>Gill</surname><given-names>BK</given-names></name></person-group><article-title>Effect of neurokinin a, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw</article-title><source>Neurosci Lett</source><year>1991</year><volume>124</volume><issue>1</issue><fpage>49</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(91)90819-F</pub-id><?supplied-pmid 1713317?><pub-id pub-id-type="pmid">1713317</pub-id></element-citation></ref><ref id="CR193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaible</surname><given-names>HG</given-names></name><name><surname>Schmidt</surname><given-names>RF</given-names></name></person-group><article-title>Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2</article-title><source>J Physiol</source><year>1988</year><volume>403</volume><fpage>91</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1988.sp017240</pub-id><?supplied-pmid 3253427?><pub-id pub-id-type="pmid">3253427</pub-id></element-citation></ref><ref id="CR194"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birrell</surname><given-names>GJ</given-names></name><name><surname>McQueen</surname><given-names>DS</given-names></name><name><surname>Iggo</surname><given-names>A</given-names></name><name><surname>Coleman</surname><given-names>RA</given-names></name><name><surname>Grubb</surname><given-names>BD</given-names></name></person-group><article-title>PGI2-induced activation and sensitization of articular mechanonociceptors</article-title><source>Neurosci Lett</source><year>1991</year><volume>124</volume><issue>1</issue><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(91)90809-8</pub-id><?supplied-pmid 1857543?><pub-id pub-id-type="pmid">1857543</pub-id></element-citation></ref><ref id="CR195"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Kulkarni</surname><given-names>A</given-names></name><name><surname>Hauer-Jensen</surname><given-names>M</given-names></name></person-group><article-title>Calcitonin gene-related peptide and substance P regulate the intestinal radiation response</article-title><source>Clin Cancer Res</source><year>2006</year><volume>12</volume><issue>13</issue><fpage>4112</fpage><lpage>4118</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-0592</pub-id><?supplied-pmid 16818712?><pub-id pub-id-type="pmid">16818712</pub-id></element-citation></ref><ref id="CR196"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eftekhari</surname><given-names>S</given-names></name><name><surname>Salvatore</surname><given-names>CA</given-names></name><name><surname>Calamari</surname><given-names>A</given-names></name><name><surname>Kane</surname><given-names>SA</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name></person-group><article-title>Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion</article-title><source>Neuroscience.</source><year>2010</year><volume>169</volume><issue>2</issue><fpage>683</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.05.016</pub-id><?supplied-pmid 20472035?><pub-id pub-id-type="pmid">20472035</pub-id></element-citation></ref><ref id="CR197"><label>197.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>K</given-names></name><name><surname>Bolay</surname><given-names>H</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Olesen</surname><given-names>J</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Ramadan</surname><given-names>NM</given-names></name><name><surname>Tfelt-Hansen</surname><given-names>P</given-names></name><name><surname>Welch</surname><given-names>KMA</given-names></name></person-group><article-title>Neurogenic inflammatory mechanisms</article-title><source>The headaches</source><year>2006</year><edition>3</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lipincott Williams &#x00026; Wilkins</publisher-name><fpage>309</fpage><lpage>319</lpage></element-citation></ref><ref id="CR198"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrobon</surname><given-names>D</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name></person-group><article-title>Pathophysiology of migraine</article-title><source>Annu Rev Physiol</source><year>2013</year><volume>75</volume><fpage>365</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-030212-183717</pub-id><?supplied-pmid 23190076?><pub-id pub-id-type="pmid">23190076</pub-id></element-citation></ref><ref id="CR199"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covelli</surname><given-names>V</given-names></name><name><surname>Munno</surname><given-names>I</given-names></name><name><surname>Pellegrino</surname><given-names>NM</given-names></name><name><surname>Altamura</surname><given-names>M</given-names></name><name><surname>Decandia</surname><given-names>P</given-names></name><name><surname>Marcuccio</surname><given-names>C</given-names></name><etal/></person-group><article-title>Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura?</article-title><source>Acta Neurol (Napoli)</source><year>1991</year><volume>13</volume><issue>2</issue><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">1891987</pub-id></element-citation></ref><ref id="CR200"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perini</surname><given-names>F</given-names></name><name><surname>D'Andrea</surname><given-names>G</given-names></name><name><surname>Galloni</surname><given-names>E</given-names></name><name><surname>Pignatelli</surname><given-names>F</given-names></name><name><surname>Billo</surname><given-names>G</given-names></name><name><surname>Alba</surname><given-names>S</given-names></name><etal/></person-group><article-title>Plasma cytokine levels in migraineurs and controls</article-title><source>Headache.</source><year>2005</year><volume>45</volume><issue>7</issue><fpage>926</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2005.05135.x</pub-id><?supplied-pmid 15985111?><pub-id pub-id-type="pmid">15985111</pub-id></element-citation></ref><ref id="CR201"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschini</surname><given-names>A</given-names></name><name><surname>Vilotti</surname><given-names>S</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><name><surname>van den Maagdenberg</surname><given-names>AM</given-names></name><name><surname>Nistri</surname><given-names>A</given-names></name><name><surname>Fabbretti</surname><given-names>E</given-names></name></person-group><article-title>TNFalpha levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>1</issue><fpage>e52394</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0052394</pub-id><?supplied-pmid 23326332?><pub-id pub-id-type="pmid">23326332</pub-id></element-citation></ref><ref id="CR202"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanure</surname><given-names>MT</given-names></name><name><surname>Gomez</surname><given-names>RS</given-names></name><name><surname>Hurtado</surname><given-names>RC</given-names></name><name><surname>Teixeira</surname><given-names>AL</given-names></name><name><surname>Domingues</surname><given-names>RB</given-names></name></person-group><article-title>Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study</article-title><source>J Headache Pain</source><year>2010</year><volume>11</volume><issue>5</issue><fpage>427</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1007/s10194-010-0233-0</pub-id><?supplied-pmid 20556464?><pub-id pub-id-type="pmid">20556464</pub-id></element-citation></ref><ref id="CR203"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristiansen</surname><given-names>KA</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name></person-group><article-title>Neurogenic inflammation: a study of rat trigeminal ganglion</article-title><source>J Headache Pain</source><year>2010</year><volume>11</volume><issue>6</issue><fpage>485</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1007/s10194-010-0260-x</pub-id><?supplied-pmid 20931347?><pub-id pub-id-type="pmid">20931347</pub-id></element-citation></ref><ref id="CR204"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuris</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>CB</given-names></name><name><surname>Zhou</surname><given-names>MF</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Uddman</surname><given-names>R</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name></person-group><article-title>Enhanced expression of CGRP in rat trigeminal ganglion neurons during cell and organ culture</article-title><source>Brain Res</source><year>2007</year><volume>1173</volume><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2007.07.073</pub-id><?supplied-pmid 17822679?><pub-id pub-id-type="pmid">17822679</pub-id></element-citation></ref><ref id="CR205"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csati</surname><given-names>A</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Vecsei</surname><given-names>L</given-names></name><name><surname>Toldi</surname><given-names>J</given-names></name><name><surname>Fulop</surname><given-names>F</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><etal/></person-group><article-title>Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion</article-title><source>J Headache Pain</source><year>2015</year><volume>16</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.1186/s10194-015-0581-x</pub-id><?supplied-pmid 26627709?><pub-id pub-id-type="pmid">26627709</pub-id></element-citation></ref><ref id="CR206"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukacs</surname><given-names>M</given-names></name><name><surname>Haanes</surname><given-names>KA</given-names></name><name><surname>Majlath</surname><given-names>Z</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Vecsei</surname><given-names>L</given-names></name><name><surname>Warfvinge</surname><given-names>K</given-names></name><etal/></person-group><article-title>Dural administration of inflammatory soup or complete Freund's adjuvant induces activation and inflammatory response in the rat trigeminal ganglion</article-title><source>J Headache Pain</source><year>2015</year><volume>16</volume><fpage>564</fpage><pub-id pub-id-type="doi">10.1186/s10194-015-0564-y</pub-id><?supplied-pmid 26329487?><pub-id pub-id-type="pmid">26329487</pub-id></element-citation></ref><ref id="CR207"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukacs</surname><given-names>M</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Fulop</surname><given-names>F</given-names></name><name><surname>Toldi</surname><given-names>J</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name><name><surname>Vecsei</surname><given-names>L</given-names></name></person-group><article-title>Migraine, neurogenic inflammation, drug development - pharmacochemical aspects</article-title><source>Curr Med Chem</source><year>2017</year><volume>24</volume><issue>33</issue><fpage>3649</fpage><lpage>3665</lpage><pub-id pub-id-type="doi">10.2174/0929867324666170712163437</pub-id><?supplied-pmid 28707585?><pub-id pub-id-type="pmid">28707585</pub-id></element-citation></ref><ref id="CR208"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Kuris</surname><given-names>A</given-names></name><name><surname>Vecsei</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>CB</given-names></name><name><surname>Edvinsson</surname><given-names>L</given-names></name></person-group><article-title>Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2</article-title><source>Cephalalgia.</source><year>2011</year><volume>31</volume><issue>1</issue><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1177/0333102410382796</pub-id><?supplied-pmid 20851839?><pub-id pub-id-type="pmid">20851839</pub-id></element-citation></ref><ref id="CR209"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name><name><surname>Malick</surname><given-names>A</given-names></name><name><surname>Strassman</surname><given-names>AM</given-names></name></person-group><article-title>Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons</article-title><source>J Neurophysiol</source><year>1998</year><volume>79</volume><issue>2</issue><fpage>964</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1152/jn.1998.79.2.964</pub-id><?supplied-pmid 9463456?><pub-id pub-id-type="pmid">9463456</pub-id></element-citation></ref><ref id="CR210"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strassman</surname><given-names>AM</given-names></name><name><surname>Raymond</surname><given-names>SA</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name></person-group><article-title>Sensitization of meningeal sensory neurons and the origin of headaches</article-title><source>Nature.</source><year>1996</year><volume>384</volume><issue>6609</issue><fpage>560</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1038/384560a0</pub-id><?supplied-pmid 8955268?><pub-id pub-id-type="pmid">8955268</pub-id></element-citation></ref><ref id="CR211"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukacs</surname><given-names>M</given-names></name><name><surname>Warfvinge</surname><given-names>K</given-names></name><name><surname>Kruse</surname><given-names>LS</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Fulop</surname><given-names>F</given-names></name><name><surname>Toldi</surname><given-names>J</given-names></name><etal/></person-group><article-title>KYNA analogue SZR72 modifies CFA-induced dural inflammation- regarding expression of pERK1/2 and IL-1beta in the rat trigeminal ganglion</article-title><source>J Headache Pain</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>64</fpage><pub-id pub-id-type="doi">10.1186/s10194-016-0654-5</pub-id><?supplied-pmid 27377707?><pub-id pub-id-type="pmid">27377707</pub-id></element-citation></ref><ref id="CR212"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cernuda-Morollon</surname><given-names>E</given-names></name><name><surname>Martinez-Camblor</surname><given-names>P</given-names></name><name><surname>Alvarez</surname><given-names>R</given-names></name><name><surname>Larrosa</surname><given-names>D</given-names></name><name><surname>Ramon</surname><given-names>C</given-names></name><name><surname>Pascual</surname><given-names>J</given-names></name></person-group><article-title>Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine</article-title><source>Cephalalgia.</source><year>2015</year><volume>35</volume><issue>4</issue><fpage>310</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1177/0333102414535111</pub-id><?supplied-pmid 24847167?><pub-id pub-id-type="pmid">24847167</pub-id></element-citation></ref><ref id="CR213"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riesco</surname><given-names>N</given-names></name><name><surname>Cernuda-Morollon</surname><given-names>E</given-names></name><name><surname>Pascual</surname><given-names>J</given-names></name></person-group><article-title>Neuropeptides as a marker for chronic headache</article-title><source>Curr Pain Headache Rep</source><year>2017</year><volume>21</volume><issue>4</issue><fpage>18</fpage><pub-id pub-id-type="doi">10.1007/s11916-017-0618-8</pub-id><?supplied-pmid 28281109?><pub-id pub-id-type="pmid">28281109</pub-id></element-citation></ref><ref id="CR214"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cernuda-Morollon</surname><given-names>E</given-names></name><name><surname>Larrosa</surname><given-names>D</given-names></name><name><surname>Ramon</surname><given-names>C</given-names></name><name><surname>Vega</surname><given-names>J</given-names></name><name><surname>Martinez-Camblor</surname><given-names>P</given-names></name><name><surname>Pascual</surname><given-names>J</given-names></name></person-group><article-title>Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine</article-title><source>Neurology.</source><year>2013</year><volume>81</volume><issue>14</issue><fpage>1191</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a6cb72</pub-id><?supplied-pmid 23975872?><pub-id pub-id-type="pmid">23975872</pub-id></element-citation></ref><ref id="CR215"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Felice</surname><given-names>M</given-names></name><name><surname>Ossipov</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>Chichorro</surname><given-names>J</given-names></name><name><surname>Meng</surname><given-names>I</given-names></name><etal/></person-group><article-title>Triptan-induced latent sensitization: a possible basis for medication overuse headache</article-title><source>Ann Neurol</source><year>2010</year><volume>67</volume><issue>3</issue><fpage>325</fpage><lpage>337</lpage><?supplied-pmid 20373344?><pub-id pub-id-type="pmid">20373344</pub-id></element-citation></ref><ref id="CR216"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>SB</given-names></name><name><surname>Lewin</surname><given-names>GR</given-names></name><name><surname>Wall</surname><given-names>PD</given-names></name></person-group><article-title>Central hyperexcitability triggered by noxious inputs</article-title><source>Curr Opin Neurobiol</source><year>1993</year><volume>3</volume><issue>4</issue><fpage>602</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/0959-4388(93)90062-4</pub-id><?supplied-pmid 8219728?><pub-id pub-id-type="pmid">8219728</pub-id></element-citation></ref><ref id="CR217"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Doubell</surname><given-names>TP</given-names></name></person-group><article-title>The pathophysiology of chronic pain--increased sensitivity to low threshold a beta-fibre inputs</article-title><source>Curr Opin Neurobiol</source><year>1994</year><volume>4</volume><issue>4</issue><fpage>525</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/0959-4388(94)90053-1</pub-id><?supplied-pmid 7812141?><pub-id pub-id-type="pmid">7812141</pub-id></element-citation></ref><ref id="CR218"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Salter</surname><given-names>MW</given-names></name></person-group><article-title>Neuronal plasticity: increasing the gain in pain</article-title><source>Science.</source><year>2000</year><volume>288</volume><issue>5472</issue><fpage>1765</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.1126/science.288.5472.1765</pub-id><?supplied-pmid 10846153?><pub-id pub-id-type="pmid">10846153</pub-id></element-citation></ref><ref id="CR219"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodick</surname><given-names>D</given-names></name><name><surname>Silberstein</surname><given-names>S</given-names></name></person-group><article-title>Central sensitization theory of migraine: clinical implications</article-title><source>Headache.</source><year>2006</year><volume>46</volume><issue>Suppl 4</issue><fpage>S182</fpage><lpage>S191</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00602.x</pub-id><?supplied-pmid 17078850?><pub-id pub-id-type="pmid">17078850</pub-id></element-citation></ref><ref id="CR220"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greene</surname><given-names>CS</given-names></name></person-group><article-title>Neuroplasticity and sensitization</article-title><source>J Am Dent Assoc</source><year>2009</year><volume>140</volume><issue>6</issue><fpage>676</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.14219/jada.archive.2009.0253</pub-id><?supplied-pmid 19491163?><pub-id pub-id-type="pmid">19491163</pub-id></element-citation></ref><ref id="CR221"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salter</surname><given-names>MW</given-names></name></person-group><article-title>Cellular neuroplasticity mechanisms mediating pain persistence</article-title><source>J Orofac Pain</source><year>2004</year><volume>18</volume><issue>4</issue><fpage>318</fpage><lpage>324</lpage><?supplied-pmid 15636015?><pub-id pub-id-type="pmid">15636015</pub-id></element-citation></ref><ref id="CR222"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coderre</surname><given-names>TJ</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Vaccarino</surname><given-names>AL</given-names></name><name><surname>Melzack</surname><given-names>R</given-names></name></person-group><article-title>Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence</article-title><source>Pain.</source><year>1993</year><volume>52</volume><issue>3</issue><fpage>259</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/0304-3959(93)90161-H</pub-id><?supplied-pmid 7681556?><pub-id pub-id-type="pmid">7681556</pub-id></element-citation></ref><ref id="CR223"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Thompson</surname><given-names>SW</given-names></name></person-group><article-title>The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states</article-title><source>Pain.</source><year>1991</year><volume>44</volume><issue>3</issue><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/0304-3959(91)90100-C</pub-id><?supplied-pmid 1828878?><pub-id pub-id-type="pmid">1828878</pub-id></element-citation></ref><ref id="CR224"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Cutrer</surname><given-names>MF</given-names></name><name><surname>Yarnitsky</surname><given-names>D</given-names></name></person-group><article-title>The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine</article-title><source>Brain.</source><year>2000</year><volume>123</volume><issue>Pt 8</issue><fpage>1703</fpage><lpage>1709</lpage><pub-id pub-id-type="doi">10.1093/brain/123.8.1703</pub-id><?supplied-pmid 10908199?><pub-id pub-id-type="pmid">10908199</pub-id></element-citation></ref><ref id="CR225"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selby</surname><given-names>G</given-names></name><name><surname>Lance</surname><given-names>JW</given-names></name></person-group><article-title>Observations on 500 cases of migraine and allied vascular headache</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1960</year><volume>23</volume><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1136/jnnp.23.1.23</pub-id><?supplied-pmid 14444681?><pub-id pub-id-type="pmid">14444681</pub-id></element-citation></ref><ref id="CR226"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartsch</surname><given-names>T</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater</article-title><source>Brain.</source><year>2003</year><volume>126</volume><issue>Pt 8</issue><fpage>1801</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1093/brain/awg190</pub-id><?supplied-pmid 12821523?><pub-id pub-id-type="pmid">12821523</pub-id></element-citation></ref><ref id="CR227"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebersberger</surname><given-names>A</given-names></name><name><surname>Ringkamp</surname><given-names>M</given-names></name><name><surname>Reeh</surname><given-names>PW</given-names></name><name><surname>Handwerker</surname><given-names>HO</given-names></name></person-group><article-title>Recordings from brain stem neurons responding to chemical stimulation of the subarachnoid space</article-title><source>J Neurophysiol</source><year>1997</year><volume>77</volume><issue>6</issue><fpage>3122</fpage><lpage>3133</lpage><pub-id pub-id-type="doi">10.1152/jn.1997.77.6.3122</pub-id><?supplied-pmid 9212262?><pub-id pub-id-type="pmid">9212262</pub-id></element-citation></ref><ref id="CR228"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schepelmann</surname><given-names>K</given-names></name><name><surname>Ebersberger</surname><given-names>A</given-names></name><name><surname>Pawlak</surname><given-names>M</given-names></name><name><surname>Oppmann</surname><given-names>M</given-names></name><name><surname>Messlinger</surname><given-names>K</given-names></name></person-group><article-title>Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat</article-title><source>Neuroscience.</source><year>1999</year><volume>90</volume><issue>2</issue><fpage>543</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(98)00423-0</pub-id><?supplied-pmid 10215158?><pub-id pub-id-type="pmid">10215158</pub-id></element-citation></ref><ref id="CR229"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshinsky</surname><given-names>ML</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name></person-group><article-title>Neurochemistry of trigeminal activation in an animal model of migraine</article-title><source>Headache.</source><year>2006</year><volume>46</volume><issue>Suppl 1</issue><fpage>S39</fpage><lpage>S44</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00489.x</pub-id><?supplied-pmid 16927963?><pub-id pub-id-type="pmid">16927963</pub-id></element-citation></ref><ref id="CR230"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwedt</surname><given-names>TJ</given-names></name><name><surname>Larson-Prior</surname><given-names>L</given-names></name><name><surname>Coalson</surname><given-names>RS</given-names></name><name><surname>Nolan</surname><given-names>T</given-names></name><name><surname>Mar</surname><given-names>S</given-names></name><name><surname>Ances</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis</article-title><source>Pain Med</source><year>2014</year><volume>15</volume><issue>1</issue><fpage>154</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1111/pme.12267</pub-id><?supplied-pmid 24165094?><pub-id pub-id-type="pmid">24165094</pub-id></element-citation></ref><ref id="CR231"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>KM</given-names></name><name><surname>Nagesh</surname><given-names>V</given-names></name><name><surname>Aurora</surname><given-names>SK</given-names></name><name><surname>Gelman</surname><given-names>N</given-names></name></person-group><article-title>Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?</article-title><source>Headache.</source><year>2001</year><volume>41</volume><issue>7</issue><fpage>629</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1046/j.1526-4610.2001.041007629.x</pub-id><?supplied-pmid 11554950?><pub-id pub-id-type="pmid">11554950</pub-id></element-citation></ref></ref-list></back></article>